Pieter Jelle Visser

Publikationer
Populärvetenskap och samverkan

Artiklar

Article: ALZHEIMERS & DEMENTIA. 2024;20(5):3429-3441
Investigating reliable amyloid accumulation in Centiloids: Results from the AMYPAD Prognostic and Natural History Study
Bollack A; Collij LE; Garcia DV; Shekari M; Altomare D; Payoux P; Dubois B; Grau-Rivera O; Boada M; Marquie M; Nordberg A; Walker Z; Scheltens P; Scholl M; Wolz R; Schott JM; Gismondi R; Stephens A; Buckley C; Frisoni GB; Hanseeuw B; Visser PJ; Vandenberghe R; Drzezga A; Yaqub M; Boellaard R; Gispert JD; Markiewicz P; Cash DM; Farrar G; Barkhof F
Article: ALZHEIMERS & DEMENTIA. 2024;20(3):1868-1880
Contributions of amyloid beta and cerebral small vessel disease in clinical decline
Moonen JEF; Haan R; Bos I; Teunissen C; van de Giessen E; Tomassen J; den Braber A; van der Landen SM; de Geus EJC; Legdeur N; van Harten AC; Trieu C; de Boer C; Kroeze L; Barkhof F; Visser PJ; van der Flier WM
Article: NATURE AGING. 2024;4(1):33-47
Cerebrospinal fluid proteomics in patients with Alzheimer's disease reveals five molecular subtypes with distinct genetic risk profiles
Tijms BM; Vromen EM; Mjaavatten O; Holstege H; Reus LM; van der Lee S; Wesenhagen KEJ; Lorenzini L; Vermunt L; Venkatraghavan V; Tesi N; Tomassen J; den Braber A; Goossens J; Vanmechelen E; Barkhof F; Pijnenburg YAL; van der Flier WM; Teunissen CE; Berven FS; Visser PJ
Article: DIGITAL HEALTH. 2024;10:20552076241238133
Feasibility and usability of remote monitoring in Alzheimer's disease
Muurling M; de Boer C; Hinds C; Atreya A; Doherty A; Alepopoulos V; Curcic J; Brem A-K; Conde P; Kuruppu S; Morato X; Saletti V; Galluzzi S; Vilarino Luis E; Cardoso S; Stukelj T; Kramberger MG; Roik D; Koychev I; Hopoy A-C; Schwertner E; Gkioka M; Aarsland D; Visser PJ
Article: JPAD-JOURNAL OF PREVENTION OF ALZHEIMERS DISEASE. 2024;11(2):329-338
Validation, Deployment, and Real-World Implementation of a Modular Toolbox for Alzheimer's Disease Detection and Dementia Risk Reduction: The AD-RIDDLE Project
Malzbender K; Barbarino P; Ferrell PB; Bradshaw A; Brookes AJ; Diaz C; van der Flier WM; Georges J; Hansson O; Hartmanis M; Jonsson L; Krishnan R; MacLeod T; Mangialasche F; Mecocci P; Minguillon C; Middleton L; Pla S; Sardi SP; Scholl M; Suarez-Calvet M; Weidner W; Visser PJ; Zetterberg H; Bose N; Solomon A; Kivipelto M
Article: NPJ DIGITAL MEDICINE. 2023;6(1):234
Augmented reality versus standard tests to assess cognition and function in early Alzheimer's disease
Muurling M; de Boer C; Vairavan S; Harms RL; Chadha AS; Tarnanas I; Luis EV; Religa D; Gjestsen MT; Galluzzi S; Sala MI; Koychev I; Hausner L; Gkioka M; Aarsland D; Visser PJ; Brem A-K
Article: JOURNAL OF NEUROINFLAMMATION. 2023;20(1):298
Longitudinal cerebrospinal fluid measurements show glial hypo- and hyperactivation in predementia Alzheimer's disease
Nordengen K; Kirsebom B-E; Richter G; Palhaugen L; Gisladottir B; Siafarikas N; Nakling A; Rongve A; Brathen G; Grontvedt GR; Gonzalez F; Waterloo K; Sharma K; Karikari T; Vromen EM; Tijms BM; Visser PJ; Selnes P; Kramberger MG; Winblad B; Blennow K; Fladby T
Article: BMC GERIATRICS. 2023;23(1):733
Is the association between blood pressure and cognition in the oldest-old modified by physical, vascular or brain pathology markers? The EMIF-AD 90+Study
Legdeur N; Moonen JE; Badissi M; Sudre CH; Pelkmans W; Gordon MF; Barkhof F; Peters M; Visser PJ; Muller M
Article: NEUROLOGY. 2023;101(19):e1850-e1862
Performance of a [¹⁸F]Flortaucipir PET Visual Read Method Across the Alzheimer Disease Continuum and in Dementia With Lewy Bodies
Coomans EM; de Koning LA; Rikken RM; Verfaillie SCJ; Visser D; den Braber A; Tomassen J; van de Beek M; Collij LE; Lemstra AW; Windhorst AD; Barkhof F; Golla SSV; Visser PJ; Scheltens P; van der Flier WM; Ossenkoppele R; van Berckel BNM; van de Giessen E
Article: ALZHEIMERS RESEARCH & THERAPY. 2023;15(1):189
Recruitment of pre-dementia participants: main enrollment barriers in a longitudinal amyloid-PET study
Bader I; Bader I; Lopes Alves I; Vallez Garcia D; Vellas B; Dubois B; Boada M; Marquie M; Altomare D; Scheltens P; Vandenberghe R; Hanseeuw B; Scholl M; Frisoni GB; Jessen F; Nordberg A; Kivipelto M; Ritchie CW; Grau-Rivera O; Molinuevo JL; Ford L; Stephens A; Gismondi R; Gispert JD; Farrar G; Barkhof F; Visser PJ; Collij LE
Article: JOURNAL OF ALZHEIMER'S DISEASE REPORTS. 2023;7(1):1299-1311
Contributions of Vascular Burden and Amyloid Abnormality to Cognitive Decline in Memory Clinic Patients.
van Gils V; Ramakers I; Jansen WJ; Banning L; Kučikienė D; Costa AS; Schulz JB; Visser PJ; Verhey F; Reetz K; Vos SJB
Article: EJNMMI PHYSICS. 2023;10(1):68
Harmonization of brain PET images in multi-center PET studies using Hoffman phantom scan
Shekari M; Verwer EE; Yaqub M; Daamen M; Buckley C; Frisoni GB; Visser PJ; Farrar G; Barkhof F; Gispert JD; Boellaard R
Article: GENOME MEDICINE. 2023;15(1):79
Multivariate GWAS of Alzheimer's disease CSF biomarker profiles implies GRIN2D in synaptic functioning.
Neumann A; Ohlei O; Küçükali F; Bos IJ; Timsina J; Vos S; Prokopenko D; Tijms BM; Andreasson U; Blennow K; Vandenberghe R; Scheltens P; Teunissen CE; Engelborghs S; Frisoni GB; Blin O; Richardson JC; Bordet R; Lleó A; Alcolea D; Popp J; Marsh TW; Gorijala P; Clark C; Peyratout G; Martinez-Lage P; Tainta M; Dobson RJB; Legido-Quigley C; Van Broeckhoven C; Tanzi RE; Ten Kate M; Lill CM; Barkhof F; Cruchaga C; Lovestone S; Streffer J; Zetterberg H; Visser PJ; Sleegers K; Bertram L; EMIF-AD & ADNI study group
Article: JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM. 2023;43(10):1726-1736
Genetic, vascular, and amyloid components of cerebral blood flow in a preclinical population
Padrela BE; Lorenzini L; Collij LE; Garcia DV; Coomans E; Ingala S; Tomassen J; Deckers Q; Shekari M; de Geus EJC; van de Giessen E; ten Kate M; Visser PJ; Barkhof F; Petr J; den Braber A; Mutsaerts HJMM
Article: BIORXIV. 2023;:2023.09.26.559021
Quantitative trait loci mapping of circulating metabolites in cerebrospinal fluid to uncover biological mechanisms involved in brain-related phenotypes.
Reus LM; Boltz T; Francia M; Bot M; Ramesh N; Koromina M; Pijnenburg YAL; den Braber A; van der Flier WM; Visser PJ; van der Lee SJ; Tijms BM; Teunissen CE; Loohuis LO; Ophoff RA
Article: BRAIN. 2023;146(9):3735-3746
Genetically identical twin-pair difference models support the amyloid cascade hypothesis
Coomans EM; Tomassen J; Ossenkoppele R; Tijms BM; Lorenzini L; ten Kate M; Collij LE; Heeman F; Rikken RM; van der Landen SM; den Hollander ME; Golla SSV; Yaqub M; Windhorst AD; Barkhof F; Scheltens P; de Geus EJC; Visser PJ; van Berckel BNM; den Braber A
Article: BMC NEUROLOGY. 2023;23(1):293
Tear biomarkers for Alzheimer's disease screening and diagnosis (the TearAD study): design and rationale of an observational longitudinal multicenter study.
van de Sande N; Ramakers IHGB; Visser PJ; Verhey FRJ; Verbraak FD; Bouwman FH; Berendschot TTJM; Nuijts RMMA; Webers CAB; Gijs M
Article: ALZHEIMERS & DEMENTIA. 2023;19(8):3563-3574
Protein disulfide isomerases as CSF biomarkers for the neuronal response to tau pathology
Wolzak K; Vermunt L; del Campo M; Jorge-Oliva M; van Ziel AM; Li KW; Smit AB; Chen-Ploktkin A; Irwin DJ; Lemstra AW; Pijnenburg Y; van der Flier W; Zetterberg H; Gobom J; Blennow K; Visser PJ; Teunissen CE; Tijms BM; Scheper W
Article: ALZHEIMERS & DEMENTIA. 2023;19(8):3350-3364
Multiomics profiling of human plasma and cerebrospinal fluid reveals ATN-derived networks and highlights causal links in Alzheimer's disease
Shi L; Xu J; Green R; Wretlind A; Homann J; Buckley NJ; Tijms BM; Vos SJB; Lill CM; ten Kate M; Engelborghs S; Sleegers K; Frisoni GB; Wallin A; Lleo A; Popp J; Martinez-Lage P; Streffer J; Barkhof F; Zetterberg H; Visser PJ; Lovestone S; Bertram L; Nevado-Holgado AJ; Proitsi P; Legido-Quigley C
Article: ALZHEIMERS & DEMENTIA. 2023;19(6):2317-2331
Whole-exome rare-variant analysis of Alzheimer's disease and related biomarker traits
Kucukali F; Neumann A; Van Dongen J; De Pooter T; Joris G; De Rijk P; Ohlei O; Dobricic V; Bos I; Vos SJB; Engelborghs S; De Roeck E; Vandenberghe R; Gabel S; Meersmans K; Tsolaki M; Verhey F; Martinez-Lage P; Tainta M; Frisoni G; Blin O; Richardson JC; Bordet R; Scheltens P; Popp J; Peyratout G; Johannsen P; Frolich L; Freund-Levi Y; Streffer J; Lovestone S; Legido-Quigley C; Ten Kate M; Barkhof F; Zetterberg H; Bertram L; Strazisar M; Visser PJ; Van Broeckhoven C; Sleegers K
Article: ALZHEIMERS & DEMENTIA. 2023;19(6):2707-2729
Outcome measures for Alzheimer's disease: A global inter-societal Delphi consensus
Ellison TS; Cappa SF; Garrett D; Georges J; Iwatsubo T; Kramer JH; Lehmann M; Lyketsos C; Maier AB; Merrilees J; Morris JC; Naismith SL; Nobili F; Pahor M; Pond D; Robinson L; Soysal P; Vandenbulcke M; Weber CJ; Visser PJ; Weiner M; Frisoni GB
Article: LANCET REGIONAL HEALTH-EUROPE. 2023;29:100657
The affordability of lecanemab, an amyloid-targeting therapy for Alzheimer's disease: an EADC-EC viewpoint
Joensson L; Wimo A; Handels R; Johansson G; Boada M; Engelborghs S; Froelich L; Jessen F; Kehoe PG; Kramberger M; de Mendon A; Ousset PJ; Scarmeas N; Visser PJ; Waldemar G; Winblad B
Article: JAMA NEUROLOGY. 2023;80(6):548-557
Clinical Effect of Early vs Late Amyloid Positron Emission Tomography in Memory Clinic Patients The AMYPAD-DPMS Randomized Clinical Trial
Altomare D; Barkhof F; Caprioglio C; Collij LE; Scheltens P; Lopes Alves I; Bouwman F; Berkhof J; van Maurik IS; Garibotto V; Moro C; Delrieu J; Payoux P; Saint-Aubert L; Hitzel A; Molinuevo JL; Grau-Rivera O; Gispert JD; Drzezga A; Jessen F; Zeyen P; Nordberg A; Savitcheva I; Jelic V; Walker Z; Edison P; Demonet J-F; Gismondi R; Farrar G; Stephens AW; Frisoni GB
Article: BRAIN COMMUNICATIONS. 2023;5(3):fcad088
Eigenvector centrality dynamics are related to Alzheimer's disease pathological changes in non-demented individuals
Lorenzini L; Ingala S; Collij LE; Wottschel V; Haller S; Blennow K; Frisoni G; Chetelat G; Payoux P; Lage-Martinez P; Ewers M; Waldman A; Wardlaw J; Ritchie C; Gispert JD; Mutsaerts HJMM; Visser PJ; Scheltens P; Tijms B; Barkhof F; Wink AM
Article: BRAIN. 2023;146(5):2045-2058
Predicting progression to Alzheimer's disease with human hippocampal progenitors exposed to serum
Maruszak A; Silajdzic E; Lee H; Murphy T; Liu B; Shi L; de Lucia C; Douiri A; Salta E; Nevado AJ; Teunissen CE; Visser PJ; Price J; Zetterberg H; Lovestone S; Thuret S
Article: SCIENTIFIC REPORTS. 2023;13(1):6531
Discovery of novel CSF biomarkers to predict progression in dementia using machine learning
Gogishvili D; Vromen EM; Hertog SK-D; Lemstra AW; Pijnenburg YAL; Visser PJ; Tijms BM; Campo MD; Abeln S; Teunissen CE; Vermunt L
Article: JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. 2023;94(4):314-320
Distinct disease mechanisms may underlie cognitive decline related to hearing loss in different age groups
Van 't Hooft JJ; Pelkmans W; Tomassen J; Smits C; Legdeur N; Den Braber A; Barkhof F; Van Berckel B; Yaqub M; Scheltens P; Pijnenburg YAL; Visser PJ; Tijms BM
Article: MEDRXIV. 2023;:2023.03.21.23287468
Axonal damage and astrocytosis are biological correlates of grey matter network integrity loss: a cohort study in autosomal dominant Alzheimer disease.
Vermunt L; Sutphen C; Dicks E; de Leeuw DM; Allegri R; Berman SB; Cash DM; Chhatwal JP; Cruchaga C; Day G; Ewers M; Farlow M; Fox NC; Ghetti B; Graff-Radford N; Hassenstab J; Jucker M; Karch CM; Kuhle J; Laske C; Levin J; Masters CL; McDade E; Mori H; Morris JC; Perrin RJ; Preische O; Schofield PR; Suárez-Calvet M; Xiong C; Scheltens P; Teunissen CE; Visser PJ; Bateman RJ; Benzinger TLS; Fagan AM; Gordon BA; Tijms BM
Article: BMC GERIATRICS. 2023;23(1):129
Physical activity levels in cognitively normal and cognitively impaired oldest-old and the association with dementia risk factors: a pilot study
Muurling M; Badissi M; de Boer C; Legdeur N; Barkhof F; van Berckel BNM; Maier AB; Pijnappels M; Visser PJ
Article: ALZHEIMERS & DEMENTIA. 2023;19(3):807-820
Cerebrospinal fluid proteomic profiling of individuals with mild cognitive impairment and suspected non-Alzheimer's disease pathophysiology
Delvenne A; Gobom J; Tijms B; Bos I; Reus LM; Dobricic V; Ten Kate M; Verhey F; Ramakers I; Scheltens P; Teunissen CE; Vandenberghe R; Schaeverbeke J; Gabel S; Popp J; Peyratout G; Martinez-Lage P; Tainta M; Tsolaki M; Freund-Levi Y; Lovestone S; Streffer J; Barkhof F; Bertram L; Blennow K; Zetterberg H; Visser PJ; Vos SJB
Article: BRAIN. 2023;146(3):1166-1174
Biomarker A plus T-: is this Alzheimer's disease or not? A combined CSF and pathology study
Vromen EM; de Boer SCM; Teunissen CE; Rozemuller A; Sieben A; Bjerke M; Visser PJ; Bouwman FH; Engelborghs S; Tijms BM
Article: JAMA NETWORK OPEN. 2023;6(1):e2250921
Analysis of Psychological Symptoms Following Disclosure of Amyloid-Positron Emission Tomography Imaging Results to Adults With Subjective Cognitive Decline
Caprioglio C; Ribaldi F; Visser LNC; Minguillon C; Collij LE; Grau-Rivera O; Zeyen P; Molinuevo JL; Domingo Gispert J; Garibotto V; Moro C; Walker Z; Edison P; Demonet J-F; Barkhof F; Scheltens P; Alves IL; Gismondi R; Farrar G; Stephens AW; Jessen F; Frisoni GB; Altomare D
Article: PLOS ONE. 2023;18(7):e0285807
Ethical challenges of using remote monitoring technologies for clinical research: A case study of the role of local research ethics committees in the RADAR-AD study
Muurling M; Pasmooij AMG; Koychev I; Roik D; Froelich L; Schwertner E; Religa D; Abdelnour C; Boada MP; Almici M; Galluzzi S; Cardoso S; de Mendonca A; Owens AP; Kuruppu S; Gjestsen MT; Lazarou I; Gkioka M; Tsolaki M; Diaz A; Gove D; Visser PJ; Aarsland D; Lucivero F; de Boer C
Article: JPAD-JOURNAL OF PREVENTION OF ALZHEIMERS DISEASE. 2023;10(3):464-470
Combined Evidence for a Long-Term, Clinical Slowing Effect of Multinutrient Intervention in Prodromal Alzheimer's Disease: Post-Hoc Analysis of 3-Year Data from the LipiDiDiet Trial
Hendrix S; Soininen H; Solomon A; Visser PJ; van Hees AMJ; Counotte DS; Nicodemus-Johnson J; Dickson SP; Blennow K; Kivipelto M; Hartmann T
Article: BRAIN COMMUNICATIONS. 2022;5(1):fcad024
Plasma biomarkers predict amyloid pathology in cognitively normal monozygotic twins after 10 years
den Braber A; Verberk IMW; Tomassen J; den Dulk B; Stoops E; Dage JL; Collij LE; Barkhof F; Willemsen G; Nivard MG; van Berckel BNM; Scheltens P; Visser PJ; de Geus EJC; Teunissen CE
Article: BMC NEUROLOGY. 2022;22(1):484
Amyloid-β and APOE genotype predict memory decline in cognitively unimpaired older individuals independently of Alzheimer's disease polygenic risk score
Tomassen J; den Braber A; van der Lee SJ; Reus LM; Konijnenberg E; Carter SF; Yaqub M; van Berckel BNM; Collij LE; Boomsma DI; de Geus EJC; Scheltens P; Herholz K; Tijms BM; Visser PJ
Article: NATURE AGING. 2022;2(11):1040-1053
CSF proteome profiling across the Alzheimer's disease spectrum reflects the multifactorial nature of the disease and identifies specific biomarker panels
del Campo M; Peeters CFW; Johnson ECB; Vermunt L; Hok-A-Hin YS; van Nee M; Chen-Plotkin A; Irwin DJ; Hu WT; Lah JJ; Seyfried NT; Dammer EB; Herradon G; Meeter LH; van Swieten J; Alcolea D; Lleo A; Levey AI; Lemstra AW; Pijnenburg YAL; Visser PJ; Tijms BM; van der Flier WM; Teunissen CE
Article: ACTA NEUROPATHOLOGICA. 2022;144(5):821-842
Genome-wide meta-analysis for Alzheimer's disease cerebrospinal fluid biomarkers
Jansen RE; van der Lee SJ; Gomez-Fonseca D; de Rojas I; Dalmasso MC; Grenier-Boley B; Zettergren A; Mishra A; Ali M; Andrade V; Bellenguez C; Kleineidam L; Kucukali F; Sung YJ; Tesi N; Vromen EM; Wightman DP; Alcolea D; Alegret M; Alvarez I; Amouyel P; Athanasiu L; Bahrami S; Bailly H; Belbin O; Bergh S; Bertram L; Biessels GJ; Blennow K; Blesa R; Boada M; Boland A; Buerger K; Carracedo A; Cervera-Carles L; Chene G; Claassen JAHR; Debette S; Deleuze J-F; de Deyn PP; Diehl-Schmid J; Djurovic S; Dols-Icardo O; Dufouil C; Duron E; Duezel E; Fladby T; Fortea J; Froelich L; Garcia-Gonzalez P; Garcia-Martinez M; Giegling I; Goldhardt O; Gobom J; Grimmer T; Haapasalo A; Hampel H; Hanon O; Hausner L; Heilmann-Heimbach S; Helisalmi S; Heneka MT; Hernandez I; Herukka S-K; Holstege H; Jarholm J; Kern S; Knapskog A-B; Koivisto AM; Kornhuber J; Kuulasmaa T; Lage C; Laske C; Leinonen V; Lewczuk P; Lleo A; de Munain AL; Lopez-Garcia S; Maier W; Marquie M; Mol MO; Montrreal L; Moreno F; Moreno-Grau S; Nicolas G; Nothen MM; Orellana A; Palhaugen L; Papma JM; Pasquier F; Perneczky R; Peters O; Pijnenburg YAL; Popp J; Posthuma D; Pozueta A; Priller J; Puerta R; Quintela I; Ramakers I; Rodriguez-Rodriguez E; Rujescu D; Saltvedt I; Sanchez-Juan P; Scheltens P; Scherbaum N; Schmid M; Schneider A; Selbaek G; Selnes P; Shadrin A; Skoog I; Soininen H; Tarraga L; Teipel S; Tijms B; Tsolaki M; Van Broeckhoven C; Van Dongen J; van Swieten JC; Vandenberghe R; Vidal J-S; Visser PJ; Vogelgsang J; Waern M; Wagner M; Wiltfang J; Wittens MMJ; Zetterberg H; Zulaica M; van Duijn CM; Bjerke M; Engelborghs S; Jessen F; Teunissen CE; Pastor P; Hiltunen M; Ingelsson M; Andreassen OA; Clarimon J; Sleegers K; Ruiz A; Ramirez A; Cruchaga C; Lambert J-C; van der Flier W
Article: BRAIN. 2022;145(10):3571-3581
Genetically identical twins show comparable tau PET load and spatial distribution
Coomans EM; Tomassen J; Ossenkoppele R; Golla SSV; den Hollander M; Collij LE; Weltings E; van der Landen SM; Wolters EE; Windhorst AD; Barkhof F; de Geus EJC; Scheltens P; Visser PJ; van Berckel BNM; den Braber A
Article: ALZHEIMERS & DEMENTIA. 2022;18(10):1832-1845
Characteristics of subjective cognitive decline associated with amyloid positivity
Janssen O; Jansen WJ; Vos SJB; Boada M; Parnetti L; Gabryelewicz T; Fladby T; Molinuevo JL; Villeneuve S; Hort J; Epelbaum S; Lleo A; Engelborghs S; van der Flier WM; Landau S; Popp J; Wallin A; Scheltens P; Rikkert MO; Snyder PJ; Rowe C; Chetelat G; Ruiz A; Marquie M; Chipi E; Wolfsgruber S; Heneka M; Boecker H; Peters O; Jarholm J; Rami L; Tort-Merino A; Binette AP; Poirier J; Rosa-Neto P; Cerman J; Dubois B; Teichmann M; Alcolea D; Fortea J; Sanchez-Saudinos MB; Ebenau J; Pocnet C; Eckerstrom M; Thompson L; Villemagne V; Buckley R; Burnham S; Delarue M; Freund-Levi Y; Wallin AK; Ramakers I; Tsolaki M; Soininen H; Hampel H; Spiru L; Tijms B; Ossenkoppele R; Verhey FRJ; Jessen F; Visser PJ
Article: BRAIN COMMUNICATIONS. 2022;4(5):fcac244
Stable cerebrospinal fluid neurogranin and β-site amyloid precursor protein cleaving enzyme 1 levels differentiate predementia Alzheimer's disease patients
Kirsebom B-E; Nordengen K; Selnes P; Waterloo K; Gisladottir B; Brathen G; Aarsland D; Fladby T; Richter G; Tijms BM; Visser PJ; Nilsson J; Kramberger MG; Winblad B; Blennow K
Article: ALZHEIMERS RESEARCH & THERAPY. 2022;14(1):95
P-tau subgroups in AD relate to distinct amyloid production and synaptic integrity profiles
Wesenhagen KEJ; Tijms BM; Boonkamp L; Hoede PL; Goossens J; Dewit N; Scheltens P; Vanmechelen E; Visser PJ; Teunissen CE
Article: ACTA NEUROPATHOLOGICA COMMUNICATIONS. 2022;10(1):96
Increased CSF-decorin predicts brain pathological changes driven by Alzheimer's Aβ amyloidosis
Jiang R; Smailovic U; Haytural H; Tijms BM; Li H; Haret RM; Shevchenko G; Chen G; Abelein A; Gobom J; Frykman S; Sekiguchi M; Fujioka R; Watamura N; Sasaguri H; Nystrom S; Hammarstrom P; Saido TC; Jelic V; Syvanen S; Zetterberg H; Winblad B; Bergquist J; Visser PJ; Nilsson P
Article: GENOME MEDICINE. 2022;14(1):69
Penetrance estimation of Alzheimer disease in SORL1 loss-of-function variant carriers using a family-based strategy and stratification by APOE genotypes.
Schramm C; Charbonnier C; Zaréa A; Lacour M; Wallon D; CNRMAJ collaborators; Boland A; Deleuze J-F; Olaso R; ADES consortium; Alarcon F; Campion D; Nuel G; Nicolas G
Article: ALZHEIMERS & DEMENTIA. 2022;18(6):1119-1127
Complementary pre-screening strategies to uncover hidden prodromal and mild Alzheimer's disease: Results from the MOPEAD project
Boada M; Rodrigo A; Jessen F; Wimblad B; Kramberger M; Visser PJ; Simo R; Rodriguez-Gomez O; Ciudin A; Georges J; Dumas A; Maguire P; Krivec D; Wimo A; Valero S; Alegret M; Jamilis L; Zwan M; Sannemann L; Arrufat J; Stomrud E; Johansson G; Shering C; Glaysher B; Stewart N; Belger M; Iradier F; Campo L
Article: JMIR AGING. 2022;5(2):e33856
Assessment of Social Behavior Using a Passive Monitoring App in Cognitively Normal and Cognitively Impaired Older Adults: Observational Study
Muurling M; Reus LM; de Boer C; Wessels SC; Jagesar RR; Vorstman JAS; Kas MJH; Visser PJ
Article: CLINICAL PROTEOMICS. 2022;19(1):13
Optimized sample preparation and data analysis for TMT proteomic analysis of cerebrospinal fluid applied to the identification of Alzheimer's disease biomarkers
Weiner S; Sauer M; Visser PJ; Tijms BM; Vorontsov E; Blennow K; Zetterberg H; Gobom J
Article: BRAIN COMMUNICATIONS. 2022;4(3):fcac150
Regional associations of white matter hyperintensities and early cortical amyloid pathology
Lorenzini L; Ansems LT; Alves IL; Ingala S; Garcia DV; Tomassen J; Sudre C; Salvado G; Shekari M; Operto G; Brugulat-Serrat A; Sanchez-Benavides G; ten Kate M; Tijms B; Wink AM; Mutsaerts HJMM; den Braber A; Visser PJ; van Berckel BNM; Gispert JD; Barkhof F; Collij LE
Article: NEUROLOGY. 2022;98(17):e1692-e1703
Spatial-Temporal Patterns of β-Amyloid Accumulation A Subtype and Stage Inference Model Analysis
Collij LE; Salvado G; Wottschel V; Mastenbroek SE; Schoenmakers P; Heeman F; Aksman L; Wink AM; Berckel BNM; van de Flier WM; Scheltens P; Visser PJ; Barkhof F; Haller S; Domingo Gispert J; Alves IL
Article: WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY. 2022;23(4):264-277
Social dysfunction is transdiagnostically associated with default mode network dysconnectivity in schizophrenia and Alzheimer's disease
Saris IMJ; Aghajani M; Reus LM; Visser P-J; Pijnenburg Y; van der Wee NJA; Bilderbeck AC; Raslescu A; Malik A; Mennes M; Koops S; Arrango C; Ayuso-Mateos JL; Dawson GR; Marston H; Kas MJ; Penninx BWJH
Article: MOLECULAR PSYCHIATRY. 2022;27(4):1990-1999
Rare variants in IFFO1, DTNB, NLRC3 and SLC22A10 associate with Alzheimer's disease CSF profile of neuronal injury and inflammation
Neumann A; Kucukali F; Bos I; Vos SJB; Engelborghs S; De Pooter T; Joris G; De Rijk P; De Roeck E; Tsolaki M; Verhey F; Martinez-Lage P; Tainta M; Frisoni G; Blin O; Richardson J; Bordet R; Scheltens P; Popp J; Peyratout G; Johannsen P; Froelich L; Vandenberghe R; Freund-Levi Y; Streffer J; Lovestone S; Legido-Quigley C; ten Kate M; Barkhof F; Strazisar M; Zetterberg H; Bertram L; Visser PJ; van Broeckhoven C; Sleegers K
Article: MOLECULAR NEURODEGENERATION. 2022;17(1):27
Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer's disease
Visser PJ; Reus LM; Gobom J; Jansen I; Dicks E; van der Lee SJ; Tsolaki M; Verhey FRJ; Popp J; Martinez-Lage P; Vandenberghe R; Lleo A; Molinuevo JL; Engelborghs S; Freund-Levi Y; Froelich L; Sleegers K; Dobricic V; Lovestone S; Streffer J; Vos SJB; Bos I; Smit AB; Blennow K; Scheltens P; Teunissen CE; Bertram L; Zetterberg H; Tijms BM
Article: JAMA NEUROLOGY. 2022;79(3):228-243
Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum
Jansen WJ; Janssen O; Tijms BM; Vos SJB; Ossenkoppele R; Visser PJ
Article: ALZHEIMER'S AND DEMENTIA: DIAGNOSIS, ASSESSMENT AND DISEASE MONITORING. 2022;14(1):e12286
Effects of age, amyloid, sex, and APOE e4 on the CSF proteome in normal cognition
Wesenhagen KEJ; Gobom J; Bos I; Vos SJB; Martinez-Lage P; Popp J; Tsolaki M; Vandenberghe R; Freund-Levi Y; Verhey F; Lovestone S; Streffer J; Dobricic V; Bertram L; Blennow K; Pikkarainen M; Hallikainen M; Kuusisto J; Laakso M; Soininen H; Scheltens P; Zetterberg H; Teunissen CE; Visser PJ; Tijms BM
Article: AGING BRAIN. 2022;2:100054
Gray matter network properties show distinct associations with CSF p-tau 181 levels and amyloid status in individuals without dementia
Lorenzini L; Ingala S; Wottschel V; Wink AM; Mutsaerts HJMM; Haller S; Blennow K; O'Brien JT; Frisoni BG; Chetelat G; Payoux P; Martinez-Lage P; Waldman A; Wardlaw J; Ritchie C; Gispert JD; Visser PJ; Scheltens P; Barkhof F; Tijms BM
Article: FRONTIERS IN NEUROLOGY. 2022;13:1031091
Data and sample sharing as an enabler for large-scale biomarker research and development: The EPND perspective
Bose N; Brookes AJ; Scordis P; Visser PJ
Article: ALZHEIMER'S AND DEMENTIA: TRANSLATIONAL RESEARCH AND CLINICAL INTERVENTIONS. 2022;8(1):e12346
Abnormal cerebrospinal fluid levels of amyloid and tau are associated with cognitive decline over time in cognitively normal older adults: A monozygotic twin study
Tomassen J; den Braber A; van Der Landen SM; Konijnenberg E; Teunissen CE; Vermunt L; de Geus EJC; Boomsma DI; Scheltens P; Tijms BM; Visser PJ
Article: FRONTIERS IN AGING NEUROSCIENCE. 2022;14:840651
Genome-Wide Association Study of Alzheimer's Disease Brain Imaging Biomarkers and Neuropsychological Phenotypes in the European Medical Information Framework for Alzheimer's Disease Multimodal Biomarker Discovery Dataset
Homann J; Osburg T; Ohlei O; Dobricic V; Deecke L; Bos I; Vandenberghe R; Gabel S; Scheltens P; Teunissen CE; Engelborghs S; Frisoni G; Blin O; Richardson JC; Bordet R; Lleo A; Alcolea D; Popp J; Clark C; Peyratout G; Martinez-Lage P; Tainta M; Dobson RJB; Legido-Quigley C; Sleegers K; Van Broeckhoven C; Wittig M; Franke A; Lill CM; Blennow K; Zetterberg H; Lovestone S; Streffer J; ten Kate M; Vos SJB; Barkhof F; Visser PJ; Bertram L
Article: ALZHEIMER'S AND DEMENTIA: TRANSLATIONAL RESEARCH AND CLINICAL INTERVENTIONS. 2022;8(1):e12240
CSF proteomic signature predicts progression to Alzheimer's disease dementia
Vromen EM; del Campo Milan M; Scheltens P; Teunissen CE; Visser PJ; Tijms BM
Article: FRONTIERS IN AGING NEUROSCIENCE. 2022;14:1040001
Predicting AT(N) pathologies in Alzheimer's disease from blood-based proteomic data using neural networks
Zhang Y; Ghose U; Buckley NJ; Engelborghs S; Sleegers K; Frisoni GB; Wallin A; Lleo A; Popp J; Martinez-Lage P; Legido-Quigley C; Barkhof F; Zetterberg H; Visser PJ; Bertram L; Lovestone S; Nevado-Holgado AJ; Shi L
Article: ALZHEIMERS & DEMENTIA. 2022;18(1):29-42
Harmonizing neuropsychological assessment for mild neurocognitive disorders in Europe
Boccardi M; Monsch AU; Ferrari C; Altomare D; Berres M; Bos I; Buchmann A; Cerami C; Didic M; Festari C; Nicolosi V; Sacco L; Aerts L; Albanese E; Annoni J-M; Ballhausen N; Chicherio C; Demonet J-F; Descloux V; Diener S; Ferreira D; Georges J; Gietl A; Girtler N; Kilimann I; Kloppel S; Kustyniuk N; Mecocci P; Mella N; Pigliautile M; Seeher K; Shirk SD; Toraldo A; Brioschi-Guevara A; Chan KCG; Crane PK; Dodich A; Grazia A; Kochan NA; de Oliveira FF; Nobili F; Kukull W; Peters O; Ramakers I; Sachdev PS; Teipel S; Visser PJ; Wagner M; Weintraub S; Westman E; Froelich L; Brodaty H; Dubois B; Cappa SF; Salmon D; Winblad B; Frisoni GB; Kliegel M
Article: SCIENTIFIC DATA. 2021;8(1):312
Insights into the changes in the proteome of Alzheimer disease elucidated by a meta-analysis
Haytural H; Benfeitas R; Schedin-Weiss S; Bereczki E; Rezeli M; Unwin RD; Wang X; Dammer EB; Johnson ECB; Seyfried NT; Winblad B; Tijms BM; Visser PJ; Frykman S; Tjernberg LO
Article: NEUROBIOLOGY OF AGING. 2021;108:189-195
Genetic overlap between Alzheimer's disease and blood lipid levels
van der Linden RJ; Reus LM; De Witte W; Tijms BM; Rikkert MO; Visser PJ; Poelmans G
Article: BIOMEDICINES. 2021;9(11):1610
Sex-Specific Metabolic Pathways Were Associated with Alzheimer's Disease (AD) Endophenotypes in the European Medical Information Framework for AD Multimodal Biomarker Discovery Cohort
Xu J; Green R; Kim M; Lord J; Ebshiana A; Westwood S; Baird AL; Nevado-Holgado AJ; Shi L; Hye A; Snowden SG; Bos I; Vos SJB; Vandenberghe R; Teunissen CE; Kate MT; Scheltens P; Gabel S; Meersmans K; Blin O; Richardson J; De Roeck EE; Engelborghs S; Sleegers K; Bordet R; Rami L; Kettunen P; Tsolaki M; Verhey FRJ; Alcolea D; Lleo A; Peyratout G; Tainta M; Johannsen P; Freund-Levi Y; Froelich L; Dobricic V; Frisoni GB; Molinuevo JL; Wallin A; Popp J; Martinez-Lage P; Bertram L; Blennow K; Zetterberg H; Streffer J; Visser PJ; Lovestone S; Proitsi P; Legido-Quigley C
Article: NEUROBIOLOGY OF AGING. 2021;107:42-52
Proteomic correlates of cortical thickness in cognitively normal individuals with normal and abnormal cerebrospinal fluid beta-amyloid_1-42
Ekblad LL; Visser PJ; Tijms BM
Article: ALZHEIMERS & DEMENTIA. 2021;17(10):1628-1640
TMEM106B and CPOX are genetic determinants of cerebrospinal fluid Alzheimer's disease biomarker levels
Hong S; Dobricic V; Ohlei O; Bos I; Vos SJB; Prokopenko D; Tijms BM; Andreasson U; Blennow K; Vandenberghe R; Gabel S; Scheltens P; Teunissen CE; Engelborghs S; Frisoni G; Blin O; Richardson JC; Bordet R; Lleo A; Alcolea D; Popp J; Clark C; Peyratout G; Martinez-Lage P; Tainta M; Dobson RJB; Legido-Quigley C; Sleegers K; Van Broeckhoven C; Tanzi RE; ten Kate M; Wittig M; Franke A; Lill CM; Barkhof F; Lovestone S; Streffer J; Zetterberg H; Visser PJ; Bertram L
Article: JOURNAL OF ALZHEIMERS DISEASE. 2021;83(3):1149-1159
A Cost-Consequence Analysis of Different Screening Procedures in Alzheimer's Disease: Results from the MOPEAD Project
Wimo A; Belger M; Bon J; Jessen F; Dumas A; Kramberger MG; Jamilis L; Johansson G; Rodrigo Salas A; Gomez OR; Sannemann L; Stoekenbroek M; Gurruchaga Telleria M; Valero S; Vermunt L; Waterink L; Winblad B; Jelle Visser P; Zwan M; Boada M
Article: TRANSLATIONAL PSYCHIATRY. 2021;11(1):451
Genome-wide association study of frontotemporal dementia identifies a C9ORF72 haplotype with a median of 12-G4C2 repeats that predisposes to pathological repeat expansions
Reus LM; Jansen IE; Mol MO; van Ruissen F; van Rooij J; van Schoor NM; Tesi N; Reinders MJT; Huisman MA; Holstege H; Visser PJ; de Boer SCM; Hulsman M; Ahmad S; Amin N; Uitterlinden AG; Ikram A; van Duijn CM; Seelaar H; Ramakers IHGB; Verhey FRJ; van der Lugt A; Claassen JAHR; Biessels GJ; De Deyn PP; Scheltens P; van der Flier WM; van Swieten JC; Pijnenburg YAL; van der Lee SJ
Article: ALZHEIMERS & DEMENTIA. 2021;17(9):1452-1464
Replication study of plasma proteins relating to Alzheimer's pathology
Shi L; Winchester LM; Westwood S; Baird AL; Anand SN; Buckley NJ; Hye A; Ashton NJ; Bos I; Vos SJB; ten Kate M; Scheltens P; Teunissen CE; Vandenberghe R; Gabel S; Meersmans K; Engelborghs S; De Roeck EE; Sleegers K; Frisoni GB; Blin O; Richardson JC; Bordet R; Molinuevo JL; Rami L; Wallin A; Kettunen P; Tsolaki M; Verhey F; Lleo A; Sala I; Popp J; Peyratout G; Martinez-Lage P; Tainta M; Johannsen P; Freund-Levi Y; Froeich L; Dobricic V; Legido-Quigley C; Barkhof F; Andreasson U; Blennow K; Zetterberg H; Streffer J; Lill CM; Bertram L; Visser PJ; Kolb HC; Narayan VA; Lovestone S; Nevado-Holgado AJ
Article: PROTEOMES. 2021;9(3):36
CSF Proteomic Alzheimer's Disease-Predictive Subtypes in Cognitively Intact Amyloid Negative Individuals
Tijms BM; Gobom J; Teunissen C; Dobricic V; Tsolaki M; Verhey F; Popp J; Martinez-Lage P; Vandenberghe R; Lleo A; Molinuevo JL; Engelborghs S; Freund-Levi Y; Froelich L; Bertram L; Lovestone S; Streffer J; Vos S; Blennow K; Scheltens P; Zetterberg H; Visser PJ
Article: ALZHEIMERS & DEMENTIA. 2021;17(8):1307-1316
Identification of undiagnosed dementia cases using a web-based pre-screening tool: The MOPEAD project
Rodrigo A; Trigueros P; Jamilis L; Alegret M; Rodriguez O; Tarraga L; Gonzalez-Perez A; Kramberger M; Winblad B; Visser PJ; Jessen F; Campo L; Boada M
Article: ALZHEIMERS & DEMENTIA. 2021;17(7):1189-1204
Application of the ATN classification scheme in a population without dementia: Findings from the EPAD cohort
Ingala S; De Boer C; Masselink LA; Vergari I; Lorenzini L; Blennow K; Chetelat G; Di Perri C; Ewers M; van der Flier WM; Fox NC; Gispert JD; Haller S; Molinuevo JL; Muniz-Terrera G; Mutsaerts HJMM; Ritchie CW; Ritchie K; Schmidt M; Schwarz AJ; Vermunt L; Waldman AD; Wardlaw J; Wink AM; Wolz R; Wottschel V; Scheltens P; Visser PJ; Barkhof F
Article: NEUROLOGY. 2021;96(22):e2673-e2684
Finding Treatment Effects in Alzheimer Trials in the Face of Disease Progression Heterogeneity
Jutten RJ; Sikkes SAM; van der Flier WM; Scheltens P; Visser PJ; Tijms BM
Article: ANNALS OF NEUROLOGY. 2021;89(5):987-1000
Onset of Preclinical Alzheimer Disease in Monozygotic Twins
Konijnenberg E; Tomassen J; den Braber A; ten Kate M; Yaqub M; Mulder SD; Nivard MG; Vanderstichele H; Lammertsma AA; Teunissen CE; van Berckel BNM; Boomsma DI; Scheltens P; Tijms BM; Visser PJ
Article: ALZHEIMERS RESEARCH & THERAPY. 2021;13(1):89
Remote monitoring technologies in Alzheimer's disease: design of the RADAR-AD study
Muurling M; de Boer C; Kozak R; Religa D; Koychev I; Verheij H; Nies VJM; Duyndam A; Sood M; Froehlich H; Hannesdottir K; Erdemli G; Lucivero F; Lancaster C; Hinds C; Stravopoulos TG; Nikolopoulos S; Kompatsiaris I; Manyakov NV; Owens AP; Narayan VA; Aarsland D; Visser PJ
Article: ALZHEIMERS RESEARCH & THERAPY. 2021;13(1):64
Research diagnostic criteria for Alzheimer's disease: findings from the LipiDiDiet randomized controlled trial
Rosenberg A; Solomon A; Soininen H; Visser PJ; Blennow K; Hartmann T; Kivipelto M
Article: ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY. 2021;8(2):348-358
Amyloid-β, cortical thickness, and subsequent cognitive decline in cognitively normal oldest-old
Pelkmans W; Legdeur N; ten Kate M; Barkhof F; Yaqub MM; Holstege H; van Berckel BNM; Scheltens P; van der Flier WM; Visser PJ; Tijms BM
Article: ALZHEIMERS RESEARCH & THERAPY. 2021;13(1):2
Four subgroups based on tau levels in Alzheimer's disease observed in two independent cohorts
Duits FH; Wesenhagen KEJ; Ekblad L; Wolters E; Willemse EAJ; Scheltens P; van der Flier WM; Teunissen CE; Visser PJ; Tijms BM
Article: ALZHEIMER'S AND DEMENTIA: DIAGNOSIS, ASSESSMENT AND DISEASE MONITORING. 2021;13(1):e12124
White matter microstructure disruption in early stage amyloid pathology
Collij LE; Ingala S; Top H; Wottschel V; Stickney KE; Tomassen J; Konijnenberg E; Ten Kate M; Sudre C; Alves IL; Yaqub MM; Wink AM; Ent DVT; Scheltens P; van Berckel BNM; Visser PJ; Barkhof F; Den Braber A
Article: FRONTIERS IN AGING NEUROSCIENCE. 2021;13:712545
Plasma Proteomic Biomarkers Relating to Alzheimer's Disease: A Meta-Analysis Based on Our Own Studies
Shi L; Buckley NJJ; Bos I; Engelborghs S; Sleegers K; Frisoni GB; Wallin A; Lleo A; Popp J; Martinez-Lage P; Legido-Quigley C; Barkhof F; Zetterberg H; Visser PJ; Bertram L; Lovestone S; Nevado-Holgado AJ
Article: ALZHEIMER'S AND DEMENTIA: DIAGNOSIS, ASSESSMENT AND DISEASE MONITORING. 2021;13(1):e12130
General practitioners' attitude toward early and pre-dementia diagnosis of AD in five European countries-A MOPEAD project survey
Sannemann L; Mueller T; Waterink L; Zwan M; Wimo A; Stomrud E; Pino S; Arrufat J; Rodriguez-Gomez O; Benaque A; Bon J; Ferreira D; Johansson G; Dron A; Dumas A; Georges J; Kramberger MG; Visser PJ; Winblad B; Campo L; Boada M; Jessen F
Article: ALZHEIMERS & DEMENTIA. 2021;17(1):29-40
36-month LipiDiDiet multinutrient clinical trial in prodromal Alzheimer's disease
Soininen H; Solomon A; Visser PJ; Hendrix SB; Blennow K; Kivipelto M; Hartmann T
Article: BRAIN. 2020;143(12):3776-3792
Pathophysiological subtypes of Alzheimer's disease based on cerebrospinal fluid proteomics
Tijms BM; Gobom J; Reus L; Jansen I; Hong S; Dobricic V; Kilpert F; ten Kate M; Barkhof F; Tsolaki M; Verhey FRJ; Popp J; Martinez-Lage P; Vandenberghe R; Lle A; Molinuevo JL; Engelborghs S; Bertram L; Lovestone S; Streffer J; Vos S; Bos I; Blennow K; Scheltens P; Teunissen CE; Zetterberg H; Visser PJ
Article: SEMINARS IN ARTHRITIS AND RHEUMATISM. 2020;50(6):1535-1541
Microvascular changes of the retina in ankylosing spondylitis, and the association with cardiovascular disease - the eye for a heart study
van Bentum RE; Baniaamam M; Kinaci-Tas B; van de Kreeke JA; Kocyigit M; Tomassen J; den Braber A; Visser PJ; ter Wee MM; Serne EH; Verbraak FD; Nurmohamed MT; van der Horst-Bruinsma IE
Article: TRANSLATIONAL PSYCHIATRY. 2020;10(1):403
Genome-wide association study of Alzheimer's disease CSF biomarkers in the EMIF-AD Multimodal Biomarker Discovery dataset
Hong S; Prokopenko D; Dobricic V; Kilpert F; Bos I; Vos SJB; Tijms BM; Andreasson U; Blennow K; Vandenberghe R; Cleynen I; Gabel S; Schaeverbeke J; Scheltens P; Teunissen CE; Niemantsverdriet E; Engelborghs S; Frisoni G; Blin O; Richardson JC; Bordet R; Molinuevo JL; Rami L; Kettunen P; Wallin A; Lleo A; Sala I; Popp J; Peyratout G; Martinez-Lage P; Tainta M; Dobson RJB; Legido-Quigley C; Sleegers K; Van Broeckhoven C; ten Kate M; Barkhof F; Zetterberg H; Lovestone S; Streffer J; Wittig M; Franke A; Tanzi RE; Visser PJ; Bertram L
Article: BMJ OPEN. 2020;10(11):e038753
Vascular and metabolic risk factor differences prior to dementia diagnosis: a multidatabase case-control study using European electronic health records
Perera G; Rijnbeek PR; Alexander M; Ansell D; Avillach P; Duarte-Salles T; Gordon MF; Lapi F; Mayer MA; Pasqua A; Pedersen L; van der Lei J; Visser PJ; Stewart R
Article: JOURNAL OF ALZHEIMERS DISEASE. 2020;77(3):1353-1368
Dickkopf-1 Overexpression in vitro Nominates Candidate Blood Biomarkers Relating to Alzheimer's Disease Pathology
Shi L; Winchester LM; Liu BY; Killick R; Ribe EM; Westwood S; Baird AL; Buckley NJ; Hong S; Dobricic V; Kilpert F; Franke A; Kiddle S; Sattlecker M; Dobson R; Cuadrado A; Hye A; Ashton NJ; Morgan AR; Bos I; Vos SJB; ten Kate M; Scheltens P; Vandenberghe R; Gabel S; Meersmans K; Engelborghs S; De Roeck EE; Sleegers K; Frisoni GB; Blin O; Richardson JC; Bordet R; Molinuevo JL; Rami L; Wallin A; Kettunen P; Tsolaki M; Verhey F; Lleo A; Alcolea D; Popp J; Peyratout G; Martinez-Lage P; Tainta M; Johannsen P; Teunissen CE; Freund-Levi Y; Frolich L; Legido-Quigley C; Barkhof F; Blennow K; Rasmussen KL; Nordestgaard BG; Frikke-Schmidt R; Nielsen SF; Soininen H; Vellas B; Kloszewska I; Mecocci P; Zetterberg H; Morgan BP; Streffer J; Visser PJ; Bertram L; Nevado-Holgado AJ; Lovestone S
Article: NEUROBIOLOGY OF AGING. 2020;93:144.e1-144.e15
Degree of genetic liability for Alzheimer's disease associated with specific proteomic profiles in cerebrospinal fluid
Reus LM; Stringer S; Posthuma D; Teunissen CE; Scheltens P; Pijnenburg YAL; Visser PJ; Tijms BM
Article: JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION. 2020;21(8):1102-1107.e6
Duration of Care Trajectories in Persons With Dementia Differs According to Demographic and Clinical Characteristics
Janssen O; Vos SJB; Handels R; Vermunt L; Verheij R; Verhey FRJ; van Hout H; Visser PJ; Joling KJ
Article: NEUROLOGY. 2020;95(1):e46-e58
ATN classification and clinical progression in subjective cognitive decline: The SCIENCe project
Ebenau JL; Timmers T; Wesselman LMP; Verberk IMW; Verfaillie SCJ; Slot RER; van Harten AC; Teunissen CE; Barkhof F; van den Bosch KA; van Leeuwenstijn M; Tomassen J; den Braber A; Visser PJ; Prins ND; Sikkes SAM; Scheltens P; van Berckel BNM; van der Flier WM
Article: ALZHEIMERS RESEARCH & THERAPY. 2020;12(1):65
APOE ε4 genotype-dependent cerebrospinal fluid proteomic signatures in Alzheimer's disease
Konijnenberg E; Tijms BM; Gobom J; Dobricic V; Bos I; Vos S; Tsolaki M; Verhey F; Popp J; Martinez-Lage P; Vandenberghe R; Lleo A; Froelich L; Lovestone S; Streffer J; Bertram L; Blennow K; Teunissen CE; Veerhuis R; Smit AB; Scheltens P; Zetterberg H; Visser PJ
Article: ALZHEIMERS & DEMENTIA. 2020;16(5):750-758
Quantitative amyloid PET in Alzheimer's disease: the AMYPAD prognostic and natural history study
Alves IL; Collij LE; Altomare D; Frisoni GB; Saint-Aubert L; Payoux P; Kivipelto M; Jessen F; Drzezga A; Leeuwis A; Wink AM; Visser PJ; van Berckel BNM; Scheltens P; Gray KR; Wolz R; Stephens A; Gismondi R; Buckely C; Domingo Gispert J; Schmidt M; Ford L; Ritchie C; Farrar G; Barkhof F; Luis Molinuevo J
Article: JOURNAL OF ALZHEIMERS DISEASE. 2020;74(1):213-225
Validation of Plasma Proteomic Biomarkers Relating to Brain Amyloid Burden in the EMIF-Alzheimer's Disease Multimodal Biomarker Discovery Cohort
Westwood S; Baird AL; Anand SN; Nevado-Holgado AJ; Kormilitzin A; Shi L; Hye A; Ashton NJ; Morgan AR; Bos I; Vos SJB; Baker S; Buckley NJ; Ten Kate M; Scheltens P; Teunissen CE; Vandenberghe R; Gabel S; Meersmans K; Engelborghs S; De Roeck EE; Sleegers K; Frisoni GB; Blin O; Richardson JC; Bordet R; Molinuevo JL; Rami L; Wallin A; Kettunen P; Tsolaki M; Verhey F; Lleo A; Sala I; Popp J; Peyratout G; Martinez-Lage P; Tainta M; Johannsen P; Freund-Levi Y; Froelich L; Dobricic V; Legido-Quigley C; Bertram L; Barkhof F; Zetterberg H; Morgan BP; Streffer J; Visser PJ; Lovestone S
Article: ALZHEIMERS & DEMENTIA. 2020;16(3):461-471
Real-world evidence in Alzheimer's disease: The ROADMAP Data Cube
Janssen O; Vos SJB; Garcia-Negredo G; Tochel C; Gustavsson A; Smith M; Ly A; Nelson M; Baldwin H; Sudlow C; Bexelius C; Jindra C; Vaci N; Bauermeister S; Gallacher J; Ponjoan A; Dufouil C; Olmo JG; Pedersen L; Skoog I; Hottgenroth A; Visser PJ; van der Lei J; Diaz C
Article: ALZHEIMERS RESEARCH & THERAPY. 2020;12(1):8
Prescreening for European Prevention of Alzheimer Dementia (EPAD) trial-ready cohort: impact of AD risk factors and recruitment settings
Vermunt L; Muniz-Terrera G; ter Meulen L; Veal C; Blennow K; Campbell A; Carrie I; Delrieu J; Fauria K; Huesa Rodriguez G; Ingala S; Jenkins N; Luis Molinuevo J; Ousset P-J; Porteous D; Prins ND; Solomon A; Tom BD; Zetterberg H; Zwan M; Ritchie CW; Scheltens P; Luscan G; Brookes AJ; Visser PJ
Article: ALZHEIMERS RESEARCH & THERAPY. 2019;11(1):94
Plasma levels of soluble TREM2 and neurofilament light chain in TREM2 rare variant carriers
Ashton NJ; Suarez-Calvet M; Heslegrave A; Hye A; Razquin C; Pastor P; Sanchez-Valle R; Molinuevo JL; Visser PJ; Blennow K; Hodges AK; Zetterberg H
Article: ALZHEIMERS & DEMENTIA. 2019;15(11):1478-1488
Discovery and validation of plasma proteomic biomarkers relating to brain amyloid burden by SOMAscan assay
Shi L; Westwood S; Baird AL; Winchester L; Dobricic V; Kilpert F; Hong S; Franke A; Hye A; Ashton NJ; Morgan AR; Bos I; Vos SJB; Buckley NJ; ten Kate M; Scheltens P; Vandenberghe R; Gabel S; Meersmans K; Engelborghs S; De Roeck EE; Sleegers K; Frisoni GB; Blin O; Richardson JC; Bordet R; Molinuevo JL; Rami L; Wallin A; Kettunen P; Tsolaki M; Verhey F; Lleo A; Alcolea D; Popp J; Peyratout G; Martinez-Lage P; Tainta M; Johannsen P; Teunissen CE; Freund-Levi Y; Froelich L; Legido-Quigley C; Barkhof F; Blennow K; Zetterberg H; Baker S; Morgan BP; Streffer J; Visser PJ; Bertram L; Lovestone S; Nevado-Holgado AJ
Article: LANCET NEUROLOGY. 2019;18(11):1034-1044
Biomarker-based prognosis for people with mild cognitive impairment (ABIDE): a modelling study
van Maurik IS; Vos SJ; Bos I; Bouwman FH; Teunissen CE; Scheitens P; Barkhof F; Frolich L; Kornhuber J; Wiftfang J; Maier W; Peters O; ROther E; Nobili F; Frisoni GB; Spiru L; Freund-Levi Y; Wallin AK; Hampel H; Soininen H; Tsolaki M; Verhey F; Kloszewska I; Mecocci P; Vellas B; Lovestone S; Gailuzzi S; Herukka S-K; Santana I; Baldeiras I; de Mendonca A; Silva D; Chetelat G; Egret S; Palmqvist S; Hansson O; Visser PJ; Berkhof J; van der Flier WM
Article: ALZHEIMERS & DEMENTIA. 2019;15(7):888-898
Duration of preclinical, prodromal, and dementia stages of Alzheimer's disease in relation to age, sex, and APOE genotype
Vermunt L; Sikkes SAM; van den Hout A; Handels R; Bos I; van der Flier WM; Kern S; Ousset P-J; Maruff P; Skoog I; Verhey FRJ; Freund-Levi Y; Tsolaki M; Wallin AK; Rikkert MO; Soininen H; Spiru L; Zetterberg H; Blennow K; Scheltens P; Muniz-Terrera G; Visser PJ; Vellas B; Reynish E; Ousset PJ; Andrieu S; Burns A; Pasquier F; Frisoni G; Salmon E; Michel JP; Zekry DS; Boada M; Dartigues JF; Olde-Rikkert MGM; Rigaud AS; Winblad B; Malick A; Sinclair A; Froelich L; Scheltens P; Ribera C; Touchon J; Robert P; Salva A; Waldemar G; Bullock R; Tsolaki M; Rodriguez G; Spiru L; Jones RW; Stiens G; Stoppe G; Jonhagen EM; Cherubini A; Lage PM; Gomezisla T; Camus V; Aguera-Morales E; Lopez F; Savy S; Cantet C; Coley N
Article: ALZHEIMERS & DEMENTIA. 2019;15(6):817-827
Primary fatty amides in plasma associated with brain amyloid burden, hippocampal volume, and memory in the European Medical Information Framework for Alzheimer's Disease biomarker discovery cohort
Kim M; Snowden S; Suvitaival T; Ali A; Merkler DJ; Ahmad T; Westwood S; Baird A; Proitsi P; Nevado-Holgado A; Hye A; Bos I; Vos S; Vandenberghe R; Teunissen C; ten Kate M; Scheltens P; Gabel S; Meersmans K; Blin O; Richardson J; De Roeck E; Sleegers K; Bordet R; Rami L; Kettunen P; Tsolaki M; Verhey F; Sala I; Lleo A; Peyratout G; Tainta M; Johannsen P; Freund-Levi Y; Frolich L; Dobricic V; Engelborghs S; Frisoni GB; Molinuevo JL; Wallin A; Popp J; Martinez-Lage P; Bertram L; Barkhof F; Ashton N; Blennow K; Zetterberg H; Streffer J; Visser PJ; Lovestone S; Legido-Quigley C
Article: ALZHEIMERS & DEMENTIA. 2019;15(6):776-787
Inflammatory biomarkers in Alzheimer's disease plasma
Morgan AR; Touchard S; Leckey C; O'Hagan C; Nevado-Holgado AJ; Barkhof F; Bertram L; Blin O; Bos I; Dobricic V; Engelborghs S; Frisoni G; Froelich L; Gabel S; Johannsen P; Kettunen P; Koszewska I; Legido-Quigley C; Lleo A; Martinez-Lage P; Mecocci P; Meersmans K; Luis Molinuevo J; Peyratout G; Popp J; Richardson J; Sala I; Scheltens P; Streffer J; Soininen H; Tainta-Cuezva M; Teunissen C; Tsolaki M; Vandenberghe R; Visser PJ; Vos S; Wahlund L-O; Wallin A; Westwood S; Zetterberg H; Lovestone S; Morgan BP; Bullmore ET; Bhatti J; Chamberlain SJ; Correia MM; Crofts AL; Dickinson A; Foster AC; Kitzbichler MG; Knight C; Lynall M-E; Maurice C; O'Donnell C; Pointon LJ; Hyslop PSG; Turner L; Vertes P; Widmer B; Williams GB; Morgan BP; Leckey C; Morgan AR; O'Hagan C; Touchard S; Cavanagh J; Deith C; Farmer S; McClean J; McColl A; McPherson A; Scouller P; Sutherland M; Boddeke HWGME; Richardson JC; Khan S; Murphy P; Parker CA; Patel J; Jones D; de Boer P; Kemp J; Drevets WC; Nye JS; Wittenberg G; Isaac J; Bhattacharya A; Carruthers N; Kolb H; Pariante CM; Turkheimer F; Barker GJ; Byrom H; Cash D; Cattaneo A; Gee A; Hastings C; Mariani N; McLaughlin A; Mondelli V; Nettis M; Nikkheslat N; Randall K; Sheridan H; Simmons C; Singh N; Van Loo V; Vicente-Rodriguez M; Wood TC; Worrell C; Zajkowska Z; Plath N; Egebjerg J; Eriksson H; Gastambide F; Adams KH; Jeggo R; Thomsen C; Pederson JT; Campbell B; Moller T; Nelson B; Zorn S; O'Connor J; Attenburrow MJ; Baird A; Benjamin J; Clare S; Cowen P; Huang I-SD; Hurley S; Jones H; Lovestone S; Mada F; Nevado-Holgado A; Oladejo A; Ribe E; Smith K; Vyas A; Hughes Z; Balice-Gordon R; Duerr J; Piro JR; Sporn J; Perry VH; Cleal M; Fryatt G; Gomez-Nicola D; Mancuso R; Reynolds R; Harrison NA; Cercignani M; Clarke CL; Hoskins E; Kohn C; Murray R; Wilcock L; Wlazly D
Article: ALZHEIMERS & DEMENTIA. 2019;15(6):742-753
Longitudinal cerebrospinal fluid biomarker trajectories along the Alzheimer's disease continuum in the BIOMARKAPD study
Lleo A; Alcolea D; Martinez-Lage P; Scheltens P; Parnetti L; Poirier J; Simonsen AH; Verbeek MM; Rosa-Neto P; Slot RER; Tainta M; Izaguirre A; Reijs BLR; Farotti L; Tsolaki M; Vandenbergue R; Freund-Levi Y; Verhey FRJ; Clarimon J; Fortea J; Frolich L; Santana I; Luis Molinuevo J; Lehmann S; Visser PJ; Teunissen CE; Zetterberg H; Blennow K
Article: ALZHEIMERS & DEMENTIA. 2019;15(5):644-654
Cerebrospinal fluid biomarkers of neurodegeneration, synaptic integrity, and astroglial activation across the clinical Alzheimer's disease spectrum
Bos I; Vos S; Verhey F; Scheltens P; Teunissen C; Engelborghs S; Sleegers K; Frisoni G; Blin O; Richardson JC; Bordet R; Tsolaki M; Popp J; Peyratout G; Martinez-Lage P; Tainta M; Lleo A; Johannsen P; Freund-Levi Y; Froelich L; Vandenberghe R; Westwood S; Dobricic V; Barkhof F; Legido-Quigley C; Bertram L; Lovestone S; Streffer J; Andreasson U; Blennow K; Zetterberg H; Visser PJ
Article: ALZHEIMER'S AND DEMENTIA: TRANSLATIONAL RESEARCH AND CLINICAL INTERVENTIONS. 2019;5(1):933-938
A metabolite-based machine learning approach to diagnose Alzheimer-type dementia in blood: Results from the European Medical Information Framework for Alzheimer disease biomarker discovery cohort
Stamate D; Kim M; Proitsi P; Westwood S; Baird A; Nevado-Holgado A; Hye A; Bos I; Vos SJB; Vandenberghe R; Teunissen CE; Ten Kate M; Scheltens P; Gabel S; Meersmans K; Blin O; Richardson J; De Roeck E; Engelborghs S; Sleegers K; Bordet R; Ramit L; Kettunen P; Tsolaki M; Verhey F; Alcolea D; Lleo A; Peyratout G; Tainta M; Johannsen P; Freund-Levi Y; Frolich L; Dobricic V; Frisoni GB; Molinuevo JL; Wallin A; Popp J; Martinez-Lage P; Bertram L; Blennow K; Zetterberg H; Streffer J; Visser PJ; Lovestone S; Legido-Quigley C
Article: JPAD-JOURNAL OF PREVENTION OF ALZHEIMERS DISEASE. 2019;6(4):232-236
Alzheimer's Disease Composite Score: a Post-Hoc Analysis Using Data from the LipiDiDiet Trial in Prodromal Alzheimer's Disease
Hendrix SB; Soininen H; van Hees AMJ; Ellison N; Visser PJ; Solomon A; Attali A; Blennow K; Kivipelto M; Hartmann T
Article: ANNALS OF NEUROLOGY. 2018;84(5):729-740
Prevalence of amyloid-β pathology in distinct variants of primary progressive aphasia
Bergeron D; Gorno-Tempini ML; Rabinovici GD; Santos-Santos MA; Seeley W; Miller BL; Pijnenburg Y; Keulen MA; Groot C; van Berckel BNM; van der Flier WM; Scheltens P; Rohrer JD; Warren JD; Schott JM; Fox NC; Sanchez-Valle R; Grau-Rivera O; Gelpi E; Seelaar H; Papma JM; van Swieten JC; Hodges JR; Leyton CE; Piguet O; Rogalski EJ; Mesulam MM; Koric L; Nora K; Pariente J; Dickerson B; Mackenzie IR; Hsiung G-YR; Belliard S; Irwin DJ; Wolk DA; Grossman M; Jones M; Harris J; Mann D; Snowden JS; Chrem-Mendez P; Calandri IL; Amengual AA; Miguet-Alfonsi C; Magnin E; Magnani G; Santangelo R; Deramecourt V; Pasquier F; Mattsson N; Nilsson C; Hansson O; Keith J; Masellis M; Black SE; Matias-Guiu JA; Cabrera-Martin M-N; Paquet C; Dumurgier J; Teichmann M; Sarazin M; Bottlaender M; Dubois B; Rowe CC; Villemagne VL; Vandenberghe R; Granadillo E; Teng E; Mendez M; Meyer PT; Frings L; Lleo A; Blesa R; Fortea J; Seo SW; Diehl-Schmid J; Grimmer T; Frederiksen KS; Sanchez-Juan P; Chetelat G; Jansen W; Bouchard RW; Laforce RJ; Visser PJ; Ossenkoppele R
Article: ALZHEIMERS RESEARCH & THERAPY. 2018;10(1):100
MRI predictors of amyloid pathology: results from the EMIF-AD Multimodal Biomarker Discovery study
ten Kate M; Redolfi A; Peira E; Bos I; Vos SJ; Vandenberghe R; Gabel S; Schaeverbeke J; Scheltens P; Blin O; Richardson JC; Bordet R; Wallin A; Eckerstrom C; Molinuevo JL; Engelborghs S; Van Broeckhoven C; Martinez-Lage P; Popp J; Tsolaki M; Verhey FRJ; Baird AL; Legido-Quigley C; Bertram L; Dobricic V; Zetterberg H; Lovestone S; Streffer J; Bianchetti S; Novak GP; Revillard J; Gordon MF; Xie Z; Wottschel V; Frisoni G; Visser PJ; Barkhof F
Article: ALZHEIMERS RESEARCH & THERAPY. 2018;10(1):64
The EMIF-AD Multimodal Biomarker Discovery study: design, methods and cohort characteristics
Bos I; Vos S; Vandenberghe R; Scheltens P; Engelborghs S; Frisoni G; Luis Molinuevo J; Wallin A; Lleo A; Popp J; Martinez-Lage P; Baird A; Dobson R; Legido-Quigley C; Sleegers K; Van Broeckhoven C; Bertram L; ten Kate M; Barkhof F; Zetterberg H; Lovestone S; Streffer J; Visser PJ
Article: ALZHEIMERS & DEMENTIA. 2018;14(7):913-924
Prevalence of the apolipoprotein E ε4 allele in amyloid β positive subjects across the spectrum of Alzheimer's disease
Mattsson N; Groot C; Jansen WJ; Landau SM; Villemagne VL; Engelborghs S; Mintun MM; Lleo A; Molinuevo JL; Jagust WJ; Frisoni GB; Ivanoiu A; Chetelat G; de Oliveira CR; Rodrigue KM; Kornhuber J; Wallin A; Klimkowicz-Mrowiec A; Kandimalla R; Popp J; Aalten PP; Aarsland D; Alcolea D; Almdahl IS; Baldeiras I; van Buchem MA; Cavedo E; Chen K; Cohen AD; Foerster S; Fortea J; Frederiksen KS; Freund-Levi Y; Gill KD; Gkatzima O; Grimmer T; Hampel H; Herukka S-K; Johannsen P; van Laere K; de Leon MJ; Maier W; Marcusson J; Meulenbroek O; Mollergard HM; Morris JC; Mroczko B; Nordlund A; Prabhakar S; Peters O; Rami L; Rodriguez-Rodriguez E; Roe CM; Ruther E; Santana I; Schroder J; Seo SW; Soininen H; Spiru L; Stomrud E; Struyfs H; Teunissen CE; Verhey FRJ; Vos SJB; van Doorn LJCVW; Waldemar G; Wallin AK; Wiltfang J; Vandenberghe R; Brooks DJ; Fladby T; Rowe CC; Drzezga A; Verbeek MM; Sarazin M; Wolk DA; Fleisher AS; Klunk WE; Na DL; Sanchez-Juan P; Lee DY; Nordberg A; Tsolaki M; Camus V; Rinne JO; Fagan AM; Zetterberg H; Blennow K; Rabinovici GD; Hansson O; van Berckel BNM; van der Flier WM; Scheltens P; Visser PJ; Ossenkoppele R
Article: ALZHEIMERS & DEMENTIA. 2018;14(6):837-842
European Prevention of Alzheimer's Dementia Registry: Recruitment and prescreening approach for a longitudinal cohort and prevention trials
Vermunt L; Veal CD; ter Meulen L; Chrysostomou C; van der Flier W; Frisoni GB; Guessous I; Kivipelto M; Marizzoni M; Martinez-Lage P; Luis Molinuevo J; Porteous D; Ritchie K; Scheltens P; Ousset P-J; Ritchie CW; Luscan G; Brookes AJ; Visser PJ
Article: WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY. 2018;19(4):244-328
Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry
Lewczuk P; Riederer P; O'Bryant SE; Verbeek MM; Dubois B; Visser PJ; Jellinger KA; Engelborghs S; Ramirez A; Parnetti L; Jack CRJ; Teunissen CE; Hampel H; Lleo A; Jessen F; Glodzik L; de Leon MJ; Fagan AM; Luis Molinuevo J; Jansen WJ; Winblad B; Shaw LM; Andreasson U; Otto M; Mollenhauer B; Wiltfang J; Turner MR; Zerr I; Handels R; Thompson AG; Johansson G; Ermann N; Trojanowski JQ; Karaca I; Wagner H; Oeckl P; van Doorn LVW; Bjerke M; Kapogiannis D; Kuiperij HB; Farotti L; Li Y; Gordon BA; Epelbaum S; Vos SJB; Klijn CJM; Van Nostrand WE; Minguillon C; Schmitz M; Gallo C; Mato AL; Thibaut F; Lista S; Alcolea D; Zetterberg H; Blennow K; Kornhuber J
Article: FRONTIERS IN AGING NEUROSCIENCE. 2018;10:409
Plasma Protein Biomarkers for the Prediction of CSF Amyloid and Tau and [¹⁸F]-Flutemetamol PET Scan Result
Westwood S; Baird AL; Hye A; Ashton NJ; Nevado-Holgado AJ; Anand SN; Liu B; Newby D; Bazenet C; Kiddle SJ; Ward M; Newton B; Desai K; Hehir CT; Zanette M; Galimberti D; Parnetti L; Lleo A; Baker S; Narayan VA; van der Flier WM; Scheltens P; Teunissen CE; Visser PJ; Lovestone S
Article: FRONTIERS IN AGING NEUROSCIENCE. 2018;10:193
Amyloid-β, Tau, and Cognition in Cognitively Normal Older Individuals: Examining the Necessity to Adjust for Biomarker Status in Normative Data
Bos I; Vos SJB; Jansen WJ; Vandenberghe R; Gabel S; Estanga A; Ecay-Torres M; Tomassen J; den Braber A; Lleo A; Sala I; Wallin A; Kettunen P; Molinuevo JL; Rami L; Chetelat G; de la Sayette V; Tsolaki M; Freund-Levi Y; Johannsen P; Novak GP; Ramakers I; Verhey FR; Visser PJ
Article: JAMA PSYCHIATRY. 2018;75(1):84-95
Association of Cerebral Amyloid-β Aggregation With Cognitive Functioning in Persons Without Dementia
Jansen WJ; Ossenkoppele R; Tijms BM; Fagan AM; Hansson O; Klunk WE; van der Flier WM; Villemagne VL; Frisoni GB; Fleisher AS; Lleo A; Mintun MA; Wallin A; Engelborghs S; Na DL; Chetelat G; Molinuevo JL; Landau SM; Mattsson N; Kornhuber J; Sabri O; Rowe CC; Parnetti L; Popp J; Fladby T; Jagust WJ; Aalten P; Lee DY; Vandenberghe R; de Oliveira CR; Kapaki E; Froelich L; Ivanoiu A; Gabryelewicz T; Verbeek MM; Sanchez-Juan P; Hildebrandt H; Camus V; Zboch M; Brooks DJ; Drzezga A; Rinne JO; Newberg A; de Mendonca A; Sarazin M; Rabinovici GD; Madsen K; Kramberger MG; Nordberg A; Mok V; Mroczko B; Wolk DA; Meyer PT; Tsolaki M; Scheltens P; Verhey FRJ; Visser PJ
Article: ALZHEIMERS RESEARCH & THERAPY. 2017;9(1):101
Cerebrovascular and amyloid pathology in predementia stages: the relationship with neurodegeneration and cognitive decline
Bos I; Verhey FR; Ramakers IHGB; Jacobs HIL; Soininen H; Freund-Levi Y; Hampel H; Tsolaki M; Wallin AK; van Buchem MA; Oleksik A; Verbeek MM; Rikkert MO; van der Flier WM; Scheltens P; Aalten P; Visser PJ; Vos SJB
Article: LANCET NEUROLOGY. 2017;16(12):965-975
24-month intervention with a specific multinutrient in people with prodromal Alzheimer's disease (LipiDiDiet): a randomised, double-blind, controlled trial
Soininen H; Solomon A; Visser PJ; Hendrix SB; Blennow K; Kivipelto M; Hartmann T
Article: JOURNAL OF ALZHEIMERS DISEASE. 2017;60(4):1387-1395
Association Between Later Life Lifestyle Factors and Alzheimer's Disease Biomarkers in Non-Demented Individuals: A Longitudinal Descriptive Cohort Study
Reijs BLR; Vos SJB; Soininen H; Lotjonen J; Koikkalainen J; Pikkarainen M; Hall A; Vanninen R; Liu Y; Herukka S-K; Freund-Levi Y; Frisoni GB; Frolich L; Nobilij F; Rikkert MO; Spiru L; Tsolaki M; Wallinn AK; Scheltens P; Verhey F; Visser PJ
Article: JOURNAL OF ALZHEIMERS DISEASE. 2017;60(4):1477-1487
Cost-Utility of Using Alzheimer's Disease Biomarkers in Cerebrospinal Fluid to Predict Progression from Mild Cognitive Impairment to Dementia
Handels RLH; Wimo A; Dodel R; Kramberger MG; Visser PJ; Luis Molinuevo J; Verhey FRJ; Winblad B
Article: JOURNAL OF ALZHEIMERS DISEASE. 2017;60(3):1025-1034
Relation of Odor Identification with Alzheimer's Disease Markers in Cerebrospinal Fluid and Cognition
Reijs BLR; Ramakers IHGB; Elias-Sonnenschein L; Teunissen CE; Koel-Simmelink M; Tsolaki M; Wahlund L-O; Waldemar G; Hausner L; Johannsen P; Vanderstichele H; Verhey F; Devanand DP; Visser PJ
Article: JOURNAL OF ALZHEIMERS DISEASE. 2017;60(3):1119-1128
Memory Correlates of Alzheimer's Disease Cerebrospinal Fluid Markers: A Longitudinal Cohort Study
Reijs BLR; Ramakers IHGB; Kohler S; Teunissen CE; Koel-Simmelink M; Nathan PJ; Tsolaki M; Wahlund L-O; Waldemar G; Hausner L; Vandenberghe R; Johannsen P; Blackwell A; Vanderstichele H; Verhey F; Visser PJ
Article: JOURNAL OF ALZHEIMERS DISEASE. 2017;60(1):201-210
Current Approaches and Clinician Attitudes to the Use of Cerebrospinal Fluid Biomarkers in Diagnostic Evaluation of Dementia in Europe
Miller A-M; Balasa M; Blennow K; Gardiner M; Rutkowska A; Scheltens P; Teunissen CE; Visser PJ; Winblad B; Waldemar G; Lawlor B
Article: NEUROBIOLOGY OF AGING. 2017;56:33-40
The frequency and influence of dementia risk factors in prodromal Alzheimer's disease
Bos I; Vos SJ; Froelich L; Kornhuber J; Wiltfang J; Maier W; Peters O; Ruether E; Engelborghs S; Niemantsverdriet E; De Roeck EE; Tsolaki M; Freund-Levim Y; Johannsen P; Vandenberghe R; Lleo A; Alcolea D; Frisoni GB; Galluzzi S; Nobili F; Morbelli S; Drzezga A; Didic M; van Berckel BN; Salmon E; Bastin C; Dauby S; Santana I; Baldeiras I; de Mendonca A; Silva D; Wallin A; Nordlund A; Coloma PM; Wientzek A; Alexander M; Novak GP; Gordon MF; Wallin AK; Hampel H; Soininen H; Herukka S-K; Scheltens P; Verhey FR; Visser PJ
Article: ALZHEIMERS & DEMENTIA. 2017;13(8):903-912
Predicting progression to dementia in persons with mild cognitive impairment using cerebrospinal fluid markers
Handels RLH; Vos SJB; Kramberger MG; Jelic V; Blennow K; van Buchem M; van der Flier W; Freund-Levi Y; Hampel H; Rikkert MO; Oleksik A; Pirtosek Z; Scheltens P; Soininen H; Teunissen C; Tsolaki M; Wallin AK; Winblad B; Verhey FRJ; Visser PJ
Article: JOURNAL OF ALZHEIMERS DISEASE. 2017;58(2):537-547
Modifiable Risk Factors for Prevention of Dementia in Midlife, Late Life and the Oldest-Old: Validation of the LIBRA Index
Vos SJB; van Boxtel MPJ; Schiepers OJG; Deckers K; de Vugt M; Carriere I; Dartigues J-F; Peres K; Artero S; Ritchie K; Galluzzo L; Scafato E; Frison GB; Huisman M; Comijs HC; Sacuiu SF; Skoog I; Irving K; O'Donnell CA; Verhey FRJ; Visser PJ; Kohler S
Article: NEUROBIOLOGY OF AGING. 2017;52:167-182.e1
Clinical validity of medial temporal atrophy as a biomarker for Alzheimer's disease in the context of a structured 5-phase development framework
ten Kate M; Barkhof F; Boccardi M; Visser PJ; Jack CRJ; Lovblad K-O; Frisoni GB; Scheltens P
Article: ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2017;31(2):146-151
Early-Onset Dementia Frequency, Diagnostic Procedures, and Quality Indicators in Three European Tertiary Referral Centers
Konijnenberg E; Fereshtehnejad S-M; ten Kate M; Eriksdotter M; Scheltens P; Johannsen P; Waldemar G; Visser PJ
Article: ALZHEIMERS & DEMENTIA. 2017;13(3):285-295
Recommendations for cerebrospinal fluid Alzheimer's disease biomarkers in the diagnostic evaluation of mild cognitive impairment
Herukka S-K; Simonsen AH; Andreasen N; Baldeiras I; Bjerke M; Blennow K; Engelborghs S; Frisoni GB; Gabryelewicz T; Galluzzi S; Handels R; Kramberger MG; Kulczynska A; Luis Molinuevo J; Mroczko B; Nordberg A; Oliveira CR; Otto M; Rinne JO; Rot U; Saka E; Soininen H; Struyfs H; Suardi S; Visser PJ; Winblad B; Zetterberg H; Waldemar G
Article: ALZHEIMERS & DEMENTIA. 2017;13(3):274-284
Recommendations for CSF AD biomarkers in the diagnostic evaluation of dementia
Simonsen AH; Herukka S-K; Andreasen N; Baldeiras I; Bjerke M; Blennow K; Engelborghs S; Frisoni GB; Gabryelewicz T; Galluzzi S; Handels R; Kramberger MG; Kulczynska A; Luis Molinuevo J; Mroczko B; Nordberg A; Oliveira CR; Otto M; Rinne JO; Rot U; Saka E; Soininen H; Struyfs H; Suardi S; Visser PJ; Winblad B; Zetterberg H; Waldemar G
Article: JOURNAL OF ALZHEIMERS DISEASE. 2017;56(2):543-555
Improved Cerebrospinal Fluid-Based Discrimination between Alzheimer's Disease Patients and Controls after Correction for Ventricular Volumes
van Doorn LJCVW; Gispert JD; Kuiperij HB; Claassen JAHR; Arighi A; Baldeiras I; Blennow K; Bozzali M; Castelo-Branco M; Cavedo E; Emek-Savas DD; Eren E; Eusebi P; Farotti L; Fenoglio C; Ormaechea JF; Freund-Levi Y; Frisoni GB; Galimberti D; Genc S; Greco V; Hampel H; Herukka S-K; Liu Y; Llado A; Lleo A; Nobili FM; Oguz KK; Parnetti L; Pereira J; Picco A; Pikkarainen M; de Oliveira CR; Saka E; Salvadori N; Sanchez-Valle R; Santana I; Scarpini E; Scheltens P; Soininen H; Tarducci R; Teunissen C; Tsolaki M; Urbani A; Vilaplana E; Visser PJ; Wallin AK; Yener G; Molinuevo JL; Meulenbroek O; Verbeek MM
Article: ALZHEIMER'S AND DEMENTIA: DIAGNOSIS, ASSESSMENT AND DISEASE MONITORING. 2017;8:111-126
Consensus guidelines for lumbar puncture in patients with neurological diseases.
Engelborghs S; Niemantsverdriet E; Struyfs H; Blennow K; Brouns R; Comabella M; Dujmovic I; van der Flier W; Frölich L; Galimberti D; Gnanapavan S; Hemmer B; Hoff E; Hort J; Iacobaeus E; Ingelsson M; Jan de Jong F; Jonsson M; Khalil M; Kuhle J; Lleó A; de Mendonça A; Molinuevo JL; Nagels G; Paquet C; Parnetti L; Roks G; Rosa-Neto P; Scheltens P; Skårsgard C; Stomrud E; Tumani H; Visser PJ; Wallin A; Winblad B; Zetterberg H; Duits F; Teunissen CE
Article: CURRENT ALZHEIMER RESEARCH. 2016;13(12):1407-1413
MCI Patients in Europe: Medication and Comorbidities. The DESCRIPA Study
Tsolaki M; Papaliagkas V; Frisoni G; Jones R; Touchon J; Spiru L; Vellas B; Verhey F; Winblad B; Visser PJ
Article: PSYCHIATRY RESEARCH-NEUROIMAGING. 2016;252:26-35
Reproducibility of hippocampal atrophy rates measured with manual, FreeSurfer, AdaBoost, FSL/FIRST and the MAPS-HBSI methods in Alzheimer's disease
Cover KS; Vanschijndel RA; Versteeg A; Leung KK; Mulder ER; Jong RA; Visser PJ; Redolfi A; Revillard J; Grenier B; Manset D; Damangir S; Bosco P; Vrenken H; van Dijk BW; Frisoni GB; Barkhof F
Article: NEUROLOGY. 2016;86(1):50-58
Use of amyloid-PET to determine cutpoints for CSF markers A multicenter study
Zwan MD; Rinne JO; Hasselbalch SG; Nordberg A; Lleo A; Herukka S-K; Soininen H; Law I; Bahl JMC; Carter SF; Fortea J; Blesa R; Teunissen CE; Bouwman FH; van Berckel BNM; Visser PJ
Article: JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION. 2015;313(19):1939-1949
Prevalence of Amyloid PET Positivity in Dementia Syndromes A Meta-analysis
Ossenkoppele R; Jansen WJ; Rabinovici GD; Knol DL; van der Flier WM; van Berckel BNM; Scheltens P; Visser PJ
Article: JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION. 2015;313(19):1924-1938
Prevalence of Cerebral Amyloid Pathology in Persons Without Dementia A Meta-analysis
Jansen WJ; Ossenkoppele R; Knol DL; Tijms BM; Scheltens P; Verhey FRJ; Visser PJ
Article: BRAIN. 2015;138(Pt 5):1327-1338
Prevalence and prognosis of Alzheimer's disease at the mild cognitive impairment stage
Vos SJB; Verhey F; Froelich L; Kornhuber J; Wiltfang J; Maier W; Peters O; Ruether E; Nobili F; Morbelli S; Frisoni GB; Drzezga A; Didic M; van Berckel BNM; Simmons A; Soininen H; Kloszewska I; Mecocci P; Tsolaki M; Vellas B; Lovestone S; Muscio C; Herukka S-K; Salmon E; Bastin C; Wallin A; Nordlund A; de Mendonca A; Silva D; Santana I; Lemos R; Engelborghs S; Van der Mussele S; Freund-Levi Y; Wallin AK; Hampel H; van der Flier W; Scheltens P; Visser PJ
Article: ALZHEIMERS & DEMENTIA. 2015;11(2):195-206.e1
The use of biomarkers for the etiologic diagnosis of MCI in Europe: An EADC survey
Bocchetta M; Galluzzi S; Kehoe PG; Aguera E; Bernabei R; Bullock R; Ceccaldi M; Dartigues J-F; de Mendonca A; Didic M; Eriksdotter M; Felician O; Froelich L; Gertz H-J; Hallikainen M; Hasselbalch SG; Hausner L; Heuser I; Jessen F; Jones RW; Kurz A; Lawlor B; Lleo A; Martinez-Lage P; Mecocci P; Mehrabian S; Monsch A; Nobili F; Nordberg A; Rikkert MO; Orgogozo J-M; Pasquier F; Peters O; Salmon E; Sanchez-Castellano C; Santana I; Sarazin M; Traykov L; Tsolaki M; Visser PJ; Wallin AK; Wilcock G; Wilkinson D; Wolf H; Yener G; Zekry D; Frisoni GB
Article: CURRENT ALZHEIMER RESEARCH. 2015;12(1):69-79
Predicting Progression from Cognitive Impairment to Alzheimer's Disease with the Disease State Index
Hall A; Mattila J; Koikkalainen J; Loejonen J; Wolz R; Scheltens P; Frisoni G; Tsolaki M; Nobili F; Freund-Levi Y; Minthon L; Froelich L; Hampel H; Visser PJ; Soininen H
Article: FRONTIERS IN NEUROLOGY. 2015;6:216
The central biobank and virtual biobank of BiOMarKaPD: a resource for studies on neurodegenerative diseases
Reijs BLR; Teunissen CE; Goncharenko N; Betsou F; Blennow K; Baldeiras I; Brosseron F; Cavedo E; Fladby T; Froelich L; Gabryelewicz T; Gurvit H; Kapaki E; Koson P; Kulic L; Lehmann S; Lewczuk P; Lleo A; Maetzler W; de Mendonca A; Miller A-M; Molinuevo JL; Mollenhauer B; Parnetti L; Rot U; Schneider A; Simonsen AH; Tagliavini F; Tsolaki M; Verbeek MM; Verhey FRJ; Zboch M; Winblad B; Scheltens P; Zetterberg H; Visser PJ
Article: EPIGENOMICS. 2015;7(4):533-537
DNMT3A moderates cognitive decline in subjects with mild cognitive impairment: replicated evidence from two mild cognitive impairment cohorts
Chouliaras L; Kenis G; Visser PJ; Scheltens P; Tsolaki M; Jones RW; Kehoe PG; Graff C; Girtler NG; Wallin AK; Rikkert MO; Spiru L; Elias-Sonnenschein LS; Ramakers IHGB; Pishva E; van Os J; Steinbusch HWM; Verhey FRJ; van den Hove DLA; Rutten BPF
Article: ALZHEIMERS & DEMENTIA. 2014;10(6):713-723.e2
The cerebrospinal fluid "Alzheimer profile": Easily said, but what does it mean?
Duits FH; Teunissen CE; Bouwman FH; Visser P-J; Mattsson N; Zetterberg H; Blennow K; Hansson O; Minthon L; Andreasen N; Marcusson J; Wallin A; Rikkert MO; Tsolaki M; Parnetti L; Herukka S-K; Hampel H; De Leon MJ; Schroeder J; Aarsland D; Blankenstein MA; Scheltens P; van der Flier WM
Article: ALZHEIMERS & DEMENTIA. 2014;10(4):456-467
Automatic temporal lobe atrophy assessment in prodromal AD: Data from the DESCRIPA study
Chincarini A; Bosco P; Gemme G; Esposito M; Rei L; Squarcia S; Bellotti R; Minthon L; Frisoni G; Scheltens P; Froelich L; Soininen H; Visser P-J; Nobili F
Article: NEUROBIOLOGY OF AGING. 2013;34(8):2003-2013
Measurements of medial temporal lobe atrophy for prediction of Alzheimer's disease in subjects with mild cognitive impairment
Clerx L; van Rossum IA; Burns L; Knol DL; Scheltens P; Verhey F; Aalten P; Lapuerta P; van de Pol L; van Schijndel R; de Jong R; Barkhof F; Wolz R; Rueckert D; Bocchetta M; Tsolaki M; Nobili F; Wahlund L-O; Minthon L; Froelich L; Hampel H; Soininen H; Visser PJ
Article: PSYCHOLOGICAL MEDICINE. 2013;43(5):911-920
Anxiety is related to Alzheimer cerebrospinal fluid markers in subjects with mild cognitive impairment
Ramakers IHGB; Verhey FRJ; Scheltens P; Hampel H; Soininen H; Aalten P; Rikkert MO; Verbeek MM; Spiru L; Blennow K; Trojanowski JQ; Shaw LM; Visser PJ
Article: JOURNAL OF ALZHEIMERS DISEASE. 2013;35(2):241-246
The Association Between APOE ε4 and Alzheimer-type Dementia Among Memory Clinic Patients is Confined to those with a Higher Education. The DESCRIPA Study
Vermeiren APA; Bosma H; Visser P-J; Zeegers MP; Graff C; Ewers M; Frisoni GB; Froelich L; Hampel H; Jones RW; Kehoe PG; Lenoir H; Minthon L; Nobili FM; Rikkert MO; Rigaud A-S; Scheltens P; Soininen H; Spiru L; Tsolaki M; Wahlund L-O; Vellas B; Wilcock G; Elias-Sonnenschein LS; Verhey FRJ
Article: NEUROLOGY. 2013;80(12):1124-1132
Prediction of Alzheimer disease in subjects with amnestic and nonamnestic MCI
Vos SJB; van Rossum IA; Verhey F; Knol DL; Soininen H; Wahlund L-O; Hampel H; Tsolaki M; Minthon L; Frisoni GB; Froelich L; Nobili F; van der Flier W; Blennow K; Wolz R; Scheltens P; Visser PJ
Article: DEMENTIA AND GERIATRIC COGNITIVE DISORDERS. 2013;36(1-2):1-19
Single-Domain Amnestic Mild Cognitive Impairment Identified by Cluster Analysis Predicts Alzheimer's Disease in the European Prospective DESCRIPA Study
Damian M; Hausner L; Jekel K; Richter M; Froelich L; Almkvist O; Boada M; Bullock R; De Deyn PP; Frisoni GB; Hampel H; Jones RW; Kehoe P; Lenoir H; Minthon L; Rikkert MGMO; Rodriguez G; Scheltens P; Soininen H; Spiru L; Touchon J; Tsolaki M; Vellas B; Verhey FRJ; Winblad B; Wahlund L-O; Wilcock G; Visser PJ
Article: NEUROLOGY. 2012;79(17):1809-1816
Injury markers predict time to dementia in subjects with MCI and amyloid pathology
van Rossum IA; Vos SJB; Burns L; Knol DL; Scheltens P; Soininen H; Wahlund L-O; Hampel H; Tsolaki M; Minthon L; L'Italien G; van der Flier WM; Teunissen CE; Blennow K; Barkhof F; Rueckert D; Wolz R; Verhey F; Visser PJ
Article: NEUROBIOLOGY OF AGING. 2012;33(10):2272-2281
Test sequence of CSF and MRI biomarkers for prediction of AD in subjects with MCI
Vos S; van Rossum I; Burns L; Knol D; Scheltens P; Soininen H; Wahlund L-O; Hampel H; Tsolaki M; Minthon L; Handels R; L'Italien G; van der Flier W; Aalten P; Teunissen C; Barkhof F; Blennow K; Wolz R; Rueckert D; Verhey F; Visser PJ
Article: NEUROLOGY. 2012;78(7):468-476
Age and diagnostic performance of Alzheimer disease CSF biomarkers
Mattsson N; Rosen E; Hansson O; Andreasen N; Parnetti L; Jonsson M; Herukka S-K; van der Flier WM; Blankenstein MA; Ewers M; Rich K; Kaiser E; Verbeek MM; Rikkert MO; Tsolaki M; Mulugeta E; Aarsland D; Visser PJ; Schroeder J; Marcusson J; de Leon M; Hampel H; Scheltens P; Wallin A; Eriksdotter-Jonhagen M; Minthon L; Winblad B; Blennow K; Zetterberg H
Article: NEUROBIOLOGY OF AGING. 2012;33(1):201.e1-201.e8
The association between white matter hyperintensities and executive decline in mild cognitive impairment is network dependent
Jacobs HIL; Visser PJ; Van Boxtel MPJ; Frisoni GB; Tsolaki M; Papapostolou P; Nobili F; Wahlund L-O; Minthon L; Frolich L; Hampel H; Soininen H; van de Pol L; Scheltens P; Tan FES; Jolles J; Verhey FRJ
Article: DEMENTIA AND GERIATRIC COGNITIVE DISORDERS. 2011;32(2):135-142
Regional Differences in Effects of APOE ε4 on Cognitive Impairment in Non-Demented Subjects
Norberg J; Graff C; Almkvist O; Ewers M; Frisoni GB; Froelich L; Hampel H; Jones RW; Kehoe PG; Lenoir H; Minthon L; Nobili F; Rikkert MO; Rigaud A-S; Scheltens P; Soininen H; Spiru L; Tsolaki M; Wahlund L-O; Vellas B; Wilcock G; Elias-Sonnenschein LS; Verhey FRJ; Visser PJ
Article: NEUROBIOLOGY OF AGING. 2010;31(10):1787-1798
Cortical sources of resting EEG rhythms in mild cognitive impairment and subjective memory complaint
Babiloni C; Visser PJ; Frisoni G; De Deyn PP; Bresciani L; Jelic V; Nagels G; Rodriguez G; Rossini PM; Vecchio F; Colombo D; Verhey F; Wahlund L-O; Nobili F
Article: JOURNAL OF NUTRITION HEALTH & AGING. 2010;14(2):131-135
CONSENSUS STATEMENT ON DEMENTIA EDUCATION AND TRAINING IN EUROPE
Tsolaki M; Papaliagkas V; Anogianakis G; Bernabei R; Emre M; Frolich L; Visser PJ; Michel J-P; Pirttila T; Rikkert MO; Soininen H; Sobow T; Vellas B; Verhey F; Winblad B
Article: JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. 2009;80(10):1069-1074
White matter hyperintensities and medial temporal lobe atrophy in clinical subtypes of mild cognitive impairment: the DESCRIPA study
van de Pol LA; Verhey F; Frisoni GB; Tsolaki M; Papapostolou P; Nobili F; Wahlund L-O; Minthon L; Froelich L; Hampel H; Soininen H; Knol DL; Barkhof F; Scheltens P; Visser PJ
Article: JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION. 2009;302(4):385-393
CSF Biomarkers and Incipient Alzheimer Disease in Patients With Mild Cognitive Impairment
Mattsson N; Zetterberg H; Hansson O; Andreasen N; Parnetti L; Jonsson M; Herukka S-K; van der Flier WM; Blankenstein MA; Ewers M; Rich K; Kaiser E; Verbeek M; Tsolaki M; Mulugeta E; Rosen E; Aarsland D; Visser PJ; Schroeder J; Marcusson J; de Leon M; Hampel H; Scheltens P; Pirttilae T; Wallin A; Jonhagen ME; Minthon L; Winblad B; Blennow K
Article: LANCET NEUROLOGY. 2009;8(7):619-627
Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study
Visser PJ; Verhey F; Knol DL; Scheltens P; Wahlund L-O; Freund-Levi Y; Tsolaki M; Minthon L; Wallin AK; Hampel H; Buerger K; Pirttila T; Soininen H; Rikkert MO; Verbeek MM; Spiru L; Blennow K
Article: NEUROEPIDEMIOLOGY. 2008;30(4):254-265
Development of screening guidelines and clinical criteria for predementia Alzheimer's disease
Visser PJ; Verhey FRJ; Boada M; Bullock R; De Deyn PP; Frisoni GB; Froelich L; Hampel H; Jolles J; Jones R; Minthon L; Nobili F; Rikkert MO; Ousset P-J; Rigaud A-S; Scheltens P; Soininen H; Spiru L; Touchon J; Tsolaki M; Vellas B; Wahlund L-O; Wilcock G; Winblad B
Article: NEUROEPIDEMIOLOGY. 2007;29(1-2):29-38
The ICTUS study:: A prospective longitudinal observational study of 1,380 AD patients in Europe -: Study design and baseline characteristics of the cohort
Reynish E; Cortes F; Andrieu S; Cantet C; Rikkert MO; Melis R; Froelich L; Frisoni GB; Joensson L; Visser PJ; Ousset PJ; Vellas B
Article: NEUROLOGY. 2004;63(1):94-100
Medial temporal lobe atrophy on MRI predicts dementia in patients with mild cognitive impairment
Korf ESC; Wahlund LO; Visser PJ; Scheltens P
Visa fler

Alla övriga publikationer

Review: JOURNAL OF INTERNAL MEDICINE. 2024;295(3):281-291
People get ready! A new generation of Alzheimer's therapies may require new ways to deliver and pay for healthcare
Wahlberg K; Winblad B; Cole A; Herring WL; Ramsberg J; Torontali I; Visser P-J; Wimo A; Wollaert L; Jonsson L
Meeting abstract: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2023;75:s127-s128
PREDICTION OF ALZHEIMER'S DISEASE BIOMARK-ERS USING GENOMICS AND CEREBROSPINAL FLUID METABOLOMICS
Francia M; Ramesh N; Boltz T; Reus L; Bot M; van der Flier WM; Visser PJ; Van der Lee S; Tijms BM; Teunissen CE; Loohuis LO; Ophoff R
Meeting abstract: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2023;75:s275
Quantitative trait loci mapping of circulating metabolites in cerebrospinal fluid reveals insights into biological mechanisms
Reus L; Boltz T; Francia M; Bot M; Ramesh N; van der Flier WM; Visser PJ; Van der Lee S; Tijms BM; Loohuis LO; Teunissen CE; Ophoff R
Review: FRONTIERS IN NEUROLOGY. 2023;14:1187095
Data sharing in neurodegenerative disease research: challenges and learnings from the innovative medicines initiative public-private partnership model.
Bradshaw A; Hughes N; Vallez-Garcia D; Chokoshvili D; Owens A; Hansen C; Emmert K; Maetzler W; Killin L; Barnes R; Brookes AJ; Visser PJ; Hofmann-Apitius M; Diaz C; Steukers L
Corrigendum: JPAD-JOURNAL OF PREVENTION OF ALZHEIMERS DISEASE. 2023;10(1):151
Alzheimer's Disease Composite Score: a Post-Hoc Analysis Using Data from the LipiDiDiet Trial in Prodromal Alzheimer's Disease (vol 6, pg 232, 2019)
Hendrix SB; Soininen H; van Hees AMJ; Ellison N; Visser PJ; Solomon A; Attali A; Blennow K; Kivipelto M; Hartmann T
Meeting abstract: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2022;63:E140-E141
PROTEIN QUANTITATIVE TRAIT LOCI (PQTL) MAPPING OF THE CEREBROSPINAL FLUID PROTEOME
Reus L; Teunissen CE; Gobom J; Vos SJB; Blennow K; Zetterberg H; Bertram L; Visser PJ; Tijms BM
Corrigendum: MOLECULAR NEURODEGENERATION. 2022;17(1):37
Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer's disease (vol 17, pg 1, 2022)
Visser PJ; Reus LM; Gobom J; Jansen I; Dicks E; van der Lee SJ; Tsolaki M; Verhey FRJ; Popp J; Martinez-Lage P; Vandenberghe R; Lleo A; Molinuevo JL; Engelborghs S; Freund-Levi Y; Froelich L; Sleegers K; Dobricic V; Lovestone S; Streffer J; Vos SJB; Bos I; Smit AB; Smit AB; Blennow K; Scheltens P; Teunissen CE; Bertram L; Zetterberg H; Tijms BM; Smit AB; Blennow K; Scheltens P; Teunissen CE; Bertram L; Zetterberg H; Tijms BM
Review: FRONTIERS IN NEUROLOGY. 2022;13:1063598
The amyloid imaging for the prevention of Alzheimer's disease consortium: A European collaboration with global impact
Collij LE; Farrar G; Garcia DV; Bader I; Shekari M; Lorenzini L; Pemberton H; Altomare D; Pla S; Loor M; Markiewicz P; Yaqub M; Buckley C; Frisoni GB; Nordberg A; Payoux P; Stephens A; Gismondi R; Visser PJ; Ford L; Schmidt M; Birck C; Georges J; Mett A; Walker Z; Boada M; Drzezga A; Vandenberghe R; Hanseeuw B; Jessen F; Scholl M; Ritchie C; Lopes Alves I; Gispert JD; Barkhof F; AMYPAD C
Review: JAMA NEUROLOGY. 2019;76(9):1035-1048
Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology: A Systematic Review and Meta-analysis
Bridel C; van Wieringen WN; Zetterberg H; Tijms BM; Teunissen CE; Alvarez-Cermeno JC; Andreasson U; Axelsson M; Backstrom DC; Bartos A; Bjerke M; Blennow K; Boxer A; Brundin L; Burman J; Christensen T; Fialova L; Forsgren L; Frederiksen JL; Gisslen M; Gray E; Gunnarsson M; Hall S; Hansson O; Herbert MK; Jakobsson J; Jessen-Krut J; Janelidze S; Johannsson G; Jonsson M; Kappos L; Khademi M; Khalil M; Kuhle J; Landen M; Leinonen V; Logroscino G; Lu C-H; Lycke J; Magdalinou NK; Malaspina A; Mattsson N; Meeter LH; Mehta SR; Modvig S; Olsson T; Paterson RW; Perez-Santiago J; Piehl F; Pijnenburg YAL; Pyykko OT; Ragnarsson O; Rojas JC; Christensen JR; Sandberg L; Scherling CS; Schott JM; Sellebjerg FT; Simone IL; Skillback T; Stilund M; Sundstrom P; Svenningsson A; Tortelli R; Tortorella C; Trentini A; Troiano M; Turner MR; van Swieten JC; Vagberg M; Verbeek MM; Villar LM; Visser PJ; Wallin A; Weiss A; Wikkelso C; Wild EJ
Review: ALZHEIMERS & DEMENTIA. 2019;15(6):828-839
The MOPEAD project: Advancing patient engagement for the detection of "hidden" undiagnosed cases of Alzheimer's disease in the community
Rodriguez-Gomez O; Rodrigo A; Iradier F; Santos-Santos MA; Hundemer H; Ciudin A; Sannemann L; Zwan M; Glaysher B; Wimo A; Bonn J; Johansson G; Rodriguez I; Alegret M; Gove D; Pino S; Trigueros P; Kivipelto M; Mathews B; Ciudad A; Ferreira D; Bintener C; Gurruchaga M; Westman E; Belger M; Valero S; Maguire P; Krivec D; Kramberger M; Simo R; Garro IP; Visser PJ; Dumas A; Georges J; Jessen F; Winblad B; Shering C; Stewart N; Campo L; Boada M
Corrigendum: ALZHEIMERS RESEARCH & THERAPY. 2018;10(1):56
Cerebrovascular and amyloid pathology in predementia stages: the relationship with neurodegeneration and cognitive decline (vol 9, 101, 2017)
Bos I; Verhey FR; Ramakers IHGB; Jacobs HIL; Soininen H; Freund-Levi Y; Hampel H; Tsolaki M; Wallin AK; van Buchem MA; Oleksik A; Verbeek MM; Rikkert MO; van der Flier WM; Scheltens P; Aalten P; Visser PJ; Vos SJB
Review: LANCET NEUROLOGY. 2017;16(8):661-676
Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers
Frisoni GB; Boccardi M; Barkhof F; Blennow K; Cappa S; Chiotis K; Demonet J-F; Garibotto V; Giannakopoulos P; Gietl A; Hansson O; Herholz K; Jack CRJ; Nobili F; Nordberg A; Snyder HM; Ten Kate M; Varrone A; Albanese E; Becker S; Bossuyt P; Carrillo MC; Cerami C; Dubois B; Gallo V; Giacobini E; Gold G; Hurst S; Loenneborg A; Lovblad K-O; Mattsson N; Molinuevo J-L; Monsch AU; Mosimann U; Padovani A; Picco A; Porteri C; Ratib O; Saint-Aubert L; Scerri C; Scheltens P; Schott JM; Sonni I; Teipel S; Vineis P; Visser PJ; Yasui Y; Winblad B
Review: NATURE REVIEWS NEUROLOGY. 2015;11(1):41-55
Cerebrospinal fluid biomarkers in trials for Alzheimer and Parkinson diseases
Lleo A; Cavedo E; Parnetti L; Vanderstichele H; Herukka SK; Andreasen N; Ghidoni R; Lewczuk P; Jeromin A; Winblad B; Tsolaki M; Mroczko B; Visser PJ; Santana I; Svenningsson P; Blennow K; Aarsland D; Luis Molinuevo J; Zetterberg H; Mollenhauer B
Review: LANCET NEUROLOGY. 2014;13(6):614-629
Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria
Dubois B; Feldman HH; Jacova C; Hampel H; Molinuevo JL; Blennow K; Dekosky ST; Gauthier S; Selkoe D; Bateman R; Cappa S; Crutch S; Engelborghs S; Frisoni GB; Fox NC; Galasko D; Habert M-O; Jicha GA; Nordberg A; Pasquier F; Rabinovici G; Robert P; Rowe C; Salloway S; Sarazin M; Epelbaum S; de Souza LC; Vellas B; Visser PJ; Schneider L; Stern Y; Scheltens P; Cummings JL
Editorial comment: BIOMARKERS IN MEDICINE. 2012;6(4):363-364
Fluid biomarkers for Alzheimer's disease: standardization and recent developments
Zetterberg H; Visser PJ
Editorial comment: JOURNAL OF NUTRITION HEALTH & AGING. 2008;12(10):683-684
EADC (EUROPEAN ALZHEIMER DISEASE CONSORTIUM) RECOMMENDATIONS FOR FUTURE ALZHEIMER DISEASE RESEARCH IN EUROPE
Winblad B; Frisoni GB; Johannsen FP; Johansson G; Kehoe P; Lovestone S; Olde-Rikkert M; Reynish E; Visser PJ; Vellas B

Artiklar

Alla övriga publikationer

Nyheter från KI

Kalenderhändelser från KI